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ABSTRACT 
 
Ab initio, density functional (DFT), semi-empirical and force field methods are used 
to predict non-covalent interactions between peptides and major histocompatibility 
complex (MHC) class II receptors. Two ab initio methods are shown to be in good 
agreement for pairwise interaction of amino-acids for myelin basic protein (MBP)-
MHC II complex. These data are then used to benchmark more approximate DFT and 
semi-empirical approaches, which are shown to be significantly in error. However, in 
some cases significant improvement is apparent on inclusion of an empirical 
dispersion correction. Most promising among these cases is RM1 with the dispersion 
correction. This approach is used to predict binding for progressively larger model 
systems, up to binding of the peptide with the entire MHC receptor, and is then 
applied to snapshots taken from molecular dynamics simulation. These methods were 
then compared to literature values of IC50 as a benchmark for three datasets, two sets 
of IC50 data for closely structurally related peptides based on hen egg lysozyme 
(HEL) and myelin basic protein (MBP) and more diverse set of 22 peptides bound to 
HLA-DR1. The set of 22 peptides bound to HLA-DR1 provides a tougher test of such 
methods, especially since no crystal structure is available for these peptide-MHC 
complexes. We therefore use sequence based methods such as SYFPEITHI and 
SVMHC to generate possible binding poses, using a consensus approach to determine 
the most likely anchor residues, which are then mapped onto the crystal structure of 
an unrelated peptide bound to the same receptor. This shows that methods based on 
molecular mechanics and semi-empirical quantum mechanics can predict binding 
with reasonable accuracy, as long as a suitable method for estimation of solvation 
effects is included. The analysis also shows that the MM/GBVI method performs 
particularly well, as does the AMBER94 forcefield with Born solvation. Indeed, 
MM/GBVI can be used as an alternative to sequence based methods in generating 
binding poses, leading to still better accuracy. Finally, we investigated the influence 
of motion in implicit and explicit solvents for a set of 22 peptides. Binding free 
energies were calculated by Molecular Mechanics Generalized -Born Surface Area 
(MM/GBSA) method, but it was found that the results are worse than MM/GBVI on 
MOE, which show that the MM/GBVI approach can deliver reasonable predictions of 
peptide-MHC binding in a matter of a few seconds on a desktop computer.  
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Chapter 1: 
Introduction:  
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1. Introduction: 
In order to create and develop new drugs, we have to understand the way that a drug 
interacts with its receptor in order to affect the biological system in the body's cells. One 
important concept is understanding the chemical interactions between the drug and the 
receptor [1-3]. Non-covalent interactions have a large influence on many properties of 
biological molecules [2, 4].  For example, they affect the structure of proteins, DNA and 
RNA [2, 4], controlling the folding of nucleic acids, molecular recognition and protein-ligand 
interaction [4, 5]. Proteins, DNA and RNA are crucial for all life, and in order to study their 
functions, we need to understand their structures [6]. Molecular recognition, “which is one of 
the most important processes in our life” [4], occurs when a molecule interacts with another 
at relatively long distances through non-covalent interactions [6]. In addition, understanding 
the way that a drug or ligand interacts with a protein opens the way to design or develop 
new drugs [6].  
 
1.1 Non-Covalent interactions: 
Non-covalent interactions may be inter- or intra-molecular in nature, and occur when the 
distance between the subsystems is larger than the typical range for covalent bonds of up 
to or slightly more than 2 Å [4]. Non-covalent interactions include ionic (or electrostatic) 
interactions, hydrogen bonds and dispersion-based interactions, which include π-π stacking 
interactions between aromatic groups. Hydrogen bonding is one of the most important 
bonds in all chemical cases [7], and was recently re-defined by IUPAC as “an attractive 
interaction between a hydrogen atom from a molecule or a molecular fragment X–H in 
which X is more electronegative than H, and an atom or a group of atoms in the same or a 
different molecule, in which there is evidence of bond formation”[8]. The interaction 
energies of hydrogen bonds are between -2.4 and -12 kcal/mol [7] (1kcal/mol=4.184 
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kJ/mol), although interactions such as C—H...O or C—H...� may be rather weaker than 
that. 
 
Dispersion interactions occur between all compounds, and are particularly significant in 
those with large polarizability. π-π stacking interactions occur between aromatic groups 
without overlap of π-orbitals [9, 10].  Hydrogen bonds and stacking are the most important 
non-covalent interactions in biological complexes such as proteins and nucleic acids  [6].  
For a long time, hydrogen bonds were considered the most important interactions in such 
molecules, but with improved theoretical and experimental methods the importance of 
stacking interactions has clarified, such that stacking interaction is now believed to be 
equally important as hydrogen bonds [6].  
 
1.2 Biological background: 
1.2.1 Major Histocompatibility Complex (MHC): 
Major Histocompatibility Complex (MHC) molecules are an important class of receptor in 
the immune system of all vertebrates: in humans they are termed human leukocyte 
antigens (HLA). Their role is to bind peptides presented to cell surfaces, hence allowing 
recognition of self or non-self and stimulating appropriate immune response in the case of 
non-self. Incorrect recognition of self peptides as being non-self is implicated in a number of 
auto-immune diseases such as multiple sclerosis and rheumatoid arthritis. The exact 
mechanism of this is not known but the concept of “molecular mimicry”, in which certain 
self-peptide sequences are sufficiently similar to non-self sequences to induce immune 
attack on the body, has been proposed. Prediction of the key binding event between 
peptide and MHC is therefore desirable, both in understanding the origin of these 
debilitating diseases and in design of new therapies to treat them. 
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MHC receptors are generally separated into class I and class II.  Both have a single peptide 
binding site, which in class I is made up of a single amino-acid chain, whereas in class II the 
active site is located at the junction between two chains, as shown in Figure (1.1)[11, 12]. 
MHC class I includes heavy chain transmembrane glycoproteins α and β2-microglobulin (ß2- 
m), whereas class II consists of two transmembrane glycoprotein chains, α and β Figure 
(1.2) [12, 13].  
 
 
 
 
 
 
Figure 1.1: MHC class I (A) and class II (B). The bound peptide is shown in blue, the 
receptor chains in red and green. 
 
 
 
 
 
 
 
 
 
Figure1.2: The MHC classes from reference [13].  
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The dimensions of the peptide-binding site are around 25Å long, 10Å wide and 11Å deep 
[13]. Class II can bind with peptides from 13 to 25 residues in length, because the ends of 
peptide-binding site are open Figure (1.3). In contrast, class I binds with peptides from 8 to 
11 residues in length [14], since in class I tryptophan-167 and tyrosine-171 of the A pocket, 
along with tyrosine-84 in the F pocket, act to “close” the binding site: class II does not 
include such resides [13]. In addition, peptide binding to the MHC, in both class I and class 
II, occurs because of particular side chain residues. Many interactions are responsible for 
MHC-peptide binding, including with peptide side chain as well as between NH2 and CHO in 
the main chains of MHC and peptide [13, 14].   
 
 
 
 
 
 
 
 
 
 
Figure1.3: The MHC classes from reference [13].  
 
 
The aim of this study is understanding the non-covalent interaction between peptide and 
MHC class II receptor with the ultimate goal of designing drugs for Multiple Sclerosis (MS) 
and other auto-immune diseases.  
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1.3 Theoretical background: 
Experimental studies of relatively weak non-covalent interactions can be difficult, so 
computer simulation is an important and rapidly expanding field.  
1.3.1 Ab initio, or Wavefunction Methods: 
Ab initio methods, also known as wavefunction theory (WFT), attempt to solve from first 
principles the electronic structure of atoms and molecules. The simplest such method is 
Hartree-Fock (HF), which averages electron-electron repulsion and is the typical starting 
point of more advanced methods. The details of electron-electron repulsion that are lost in 
HF treatment are termed “electron correlation”, and most ab initio methods seek accurate 
calculation of correlation energies [4]. Such methods are typically used to calculate 
interaction energies via the supermolecular approach, in which the interaction energy is 
calculated as the difference between the energy of the complex and the energy of all 
subsystems in the super-molecular methods. This requires that the method is size 
consistent, i.e. that the energy of two atoms or molecules at infinite separation equals the 
sum of the energy of each atom or molecule. Ab initio methods that are size consistent 
include many-body perturbation theory, and full configuration interaction (CI), whereas 
truncated CI is not size consistent and so is not suitable for description of many non-
covalent interactions. 
 
The most accurate WFT method in common use for interactions in biological systems is the 
coupled cluster (CC) ansatz, which is size-consistent. CC methods can incorporate 
electronic excitations to any level, but these are typically truncated to triples, the so-called 
CCSDT method. This method , which includes single, double and triple electron excitations, 
is highly accurate but very computationally expensive and so only applicable to small model 
systems, especially in calculating dispersion interaction energy where large orbital basis 
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sets are required [15]. The CCSD(T) approach, in which triple excitations are included 
perturbatively, provides almost identical accuracy to CCSDT method with much reduced 
computational cost, and hence is widely used for studying hydrogen bonded and stacked 
complexes at less cost [4, 6, 16, 17]. This method is now widely known as the “gold 
standard” of single-reference calculations [6]. It has been shown that a CCSD(T) approach 
with complete basis set (CBS) performs very well in studying all types of non-covalent 
interactions, including those with importance in biological complexes such as hydrogen 
bond and dispersion [6]. Unfortunately, this method can be applied to systems containing 
approximately 24 atoms or less with AO basis sets approaching the basis set limit [4, 6, 17-
19], but scaling like N7 (where N is the number of electrons in the system) means that this 
approach rapidly becomes unfeasible. This method is therefore used as a benchmark for 
studying small systems [20] and for testing the performance of other methods [4, 6, 21].  
 
CCSD(T) calculations of extended complexes can be achieved by using “a medium basis 
set of a DZP-quality”, (DZP = double-ζ + polarisation) but unfortunately the cost for such 
calculation is high [4]. The problem was solved by approximating the CBS CCSD(T) 
interaction energy by using the difference between CCSD(T) and MP2 interaction energies 
(∆ECCSD(T) - ∆EMP2) eq (1.1), because this difference is less dependent on the basis set than 
either CCSD(T) or MP2 alone. 
 
∆ECBS CCSD(T) = ∆E CBS MP2 +(∆ECCSD(T) -∆EMP2) │medium basis set     (1.1) 
 
In order to calculate ∆E CBS MP2 , many extrapolation schemes have been published, such as 
that by Helgaker et al [22], which is widely used. The extrapolation is often done by using 
“systematically improved basis sets” such as aug-cc-pVDZ - aug-cc-p-VTZ or aug-cc-pVTZ-
aug-cc-pVQZ. 
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An alternative method for large systems is second order Møller-Plesset perturbation theory 
(MP2) [4, 15, 20, 23]. MP2 is widely used for studying non-covalent interaction energies [6] 
because of relatively good accuracy and computational cost, compared with CCSD(T) 
method. MP2 performs very well in calculating the energy of H-bond, but it significantly 
overestimates dispersion energy [4, 6, 15, 17, 20, 24, 25], which is one of the major 
drawbacks of this method. MP2 interaction energies are also strongly basis-set dependent 
[4, 6].  For example, by using a DZP- quality basis set, this method provides reliable 
interaction energies for non-covalent interactions, whereas these can be significantly 
overestimated using larger basis sets [4]. For complexes mainly bound by dispersion 
energy, it has been shown that MP2 with small basis sets with expanded polarisation 
functions is successful in calculating dispersion energies, for example MP2/6-31G(0.25)d, 
the results are close to CCSD(T) as benchmark data [6, 25, 26].  Moreover, MP2 with such 
small basis sets can be applied to molecules with hundreds of atoms [6].  It has been found 
that the most accurate method, after CCSD(T), for calculating interaction energies between 
amino acid residues is MP2/aug-cc-pVTZ [27]. CCSD(T) and MP2 methods “do not contain 
any parameters, but their performance for non-covalent interaction is limited” [6].  
 
The problem of MP2, overestimated the dispersion binding energy, was solved to some 
extent by the “MP2.5” approach, in which the correlation energy from MP2, which 
overestimates dispersion energy, and MP3, which underestimates dispersion energy, is 
averaged, leading to much improved performance in calculating non-covalent interactions 
[15, 28, 29]. However, the computational cost of the MP3 step means that MP2.5 is time-
consuming when compared with MP2, although it is still much less computationally 
demanding than CCSD (T) method [6]. Unfortunately, MP2.5 can not be applied for large 
systems [6, 15].  
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Werner et al have significantly improved the performance of and reduced CPU time 
required for MP2 in calculating large systems, naming their method density-fitted local MP2 
(DF-LMP2) [30]. DF-LMP2 makes use of the local nature of electron correlation to reduce 
the computational resources required for MP2 calculations. Importantly for the study of non-
covalent interactions, this also effectively eliminates basis set superposition error (BSSE), 
thereby removing the need for potentially expensive counterpoise corrections [31-34]. This 
method is successful in studying large systems especially when suitable basis sets are 
used [30]. 
 
Spin-component scaled MP2 (SCS-MP2) is a modification of MP2 method introduced by 
Grimme [35], with the aim of improving the systematic errors in results of MP2. One such 
systematic error is the overestimation of the dispersion contribution to binding energy, as 
noted above. This method depends on separation of the correlation energy resulting from 
anti-parallel and parallel spin pairs of electrons, and assigns two new scaling factors to 
these contributions. This method successfully improves the performance of MP2 method for 
dispersion energy in some cases, where the standard MP2 is overestimated [4-6, 35] . 
Unfortunately, this method leads to worse performance in calculation of hydrogen bond 
interaction energies [5, 6, 21, 36, 37].  
 
This failure of SCS-MP2 method led to development of other methods, such as SCSN-MP2 
and SCS(MI)-MP2, in which the error in interaction energy was reduced by re-
parameterization of the scaling factors. Spin-component scaled for nucleobases (SCSN) 
was developed by optimising the scaling factors against binding energy of stacked 
nucleobases, and totally neglects the anti-parallel-spin electron pairs contribution and gives 
the parallel spin contribution a scaling of 1.76 [5]. For a set of 22 complexes containing 
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hydrogen bonded, dispersion bound, and mixed complexes (the widely-used “S22” data 
set), SCSN gives an error of 0.3 kcal/mol relative to CCSD(T) benchmark [5]. SCS-MP2 for 
molecular interactions (SCS(MI)-MP2) is an improvement of SCS-MP2 approach [27, 38]. In 
this method the parallel-spin contribution and anti-parallel spin contribution scaled 1.29 and 
0.40, respectively [38]. It has been found that the performance of SCS(MI)-MP2/cc-pV(DT)Z 
is very close to CCSD(T) results which are the  benchmark data to date [38]. The speed 
and the accuracy of this method make this method suitable to study non-covalent 
interactions in large systems [27, 38]. SCS(MI)-MP2 performs very well in calculating the 
interaction energies between amino acid residues [27]. For the S22 data set, this method 
provides accurate results, better than MP2 and SCS-MP2 methods [6]. The RMSD errors 
for SCS(MI)-MP2, MP2, and SCS-MP2 are 0.31, 0.99, and 1.45 kcal/mol, respectively [6].     
 
Explicitly correlated MP2 (MP2-F12) is a new method which provides accurate results in 
calculating the interaction energy for non-covalent interaction [15, 39] . This is achieved by 
explicitly including a term for electron-electron repulsions in the Hamiltonian, which is a 
function (F12) or the inter-electron distance r12. For S22 benchmark data, the results of 
interaction energies calculated by this method with aug-cc-pVDZ basis set are more 
accurate than by the conventional MP2/AV5Z approach, and MP2-F12/AVTZ and MP2-
F12/AVQZ provide similar results to the CBS predictions [39]. The success of MP2-F12 
leads to present CCSD(T)-F12a approach [15, 39]. Explicitly correlated couple-cluster 
method with augmented double-ξ basis sets provides more accurate results – and less 
cost- than CCSD(T) standard method with same basis set [15, 39-41].   
 
1.3.2 Density Functional Theory: 
Density functional theory (DFT) is widely used in studying large systems because of the 
relatively low cost and overall good performance [4, 42, 43]. The fundamental theorems of 
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Hohenberg and Kohn [44] show that the ground state total energy of a system can be 
calculated exactly from knowledge of the electron density alone. However, the exact 
functional that would allow one to do this is not known, so current implementations of DFT 
calculate the interaction energy using approximate exchange and correlation functionals. A 
great many such functionals of varying complexity exist, employing the electron density and 
its gradient, along with exact (HF) exchange in so-called hybrid functionals. For hydrogen 
bond energy, DFT shows reliable results comparing with reference data [4].  Unfortunately, 
most standard methods in DFT fail in calculating non-local dispersion energy [4, 6, 20, 25-
27, 45-48]. The importance of dispersion energy in biological complexes means that this 
method is not suitable in such calculations. 
 
Many attempts have been made in order to include the dispersion energy in HF and DFT 
calculations. One successful approach has been reached by calculating a dispersion term 
separately by means of a damped C6R-6 formula, where R is interatomic distance and C6 is 
a dispersion coefficient, [49-52] then adding it to HF and DFT calculations eq (1.2) [4, 20, 
43].  
 
EMF-D=EMF + Edisp             (1.2) 
 
Where EMF is mean field energy (HF or DFT), and Edisp is dispersion correction. Early 
studies showed that by adding a dispersion correction to HF energy, calculation of binding 
energy of rare-gas and larger complexes can be successful [53-56]. This success led to 
many groups adding a dispersion correction term to DFT energy [49, 57-59].  
 
Grimme “recognized the need for the dispersion to be adjusted for a given functional form 
and introduced a simple scaling factor optimized for each particular density functional” [20]. 
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This method succeeds in studying non-covalent interactions, especially dispersion and 
hydrogen-binding energies [20, 27, 52].  For the S22 data set, the root mean square error 
(RMSE) for DFT (B3LYP) with TZVP basis set, with and without dispersion term, are 0.82 
and 3.28 kcal/mol, respectively. [60, 61]. Hobza and co-workers developed an alternative 
damping function using accurate CCSD(T)/CBS data. [61]. The parameters were modified 
to recover the dispersion energy in stacking and hydrogen bonded systems.  
 
In addition to the DFT-D approach, several DFT methods show promise for description of at 
least some classes of non-covalent interactions. Hybrid meta-exchange-correlation 
functional methods such as M05-2X and M06-2X present accurate calculation for non-
covalent interactions, especially dispersion interactions [62-64]. The MUE error for 
dispersion-bound complexes for M06-2X is 0.2 kcal/mol when compared with best 
estimated values for peptides. These methods have been recommended to be used in 
biochemistry calculations [6, 62, 63].  
 
Becke’s Half-and-Half functional (BHandH) “contains an equal mixture of the exact Hartree-
Fock and local density approximation for the describing of exchange energy, coupled with 
Lee, Yang and Parr’s expression for the correlation energy”. This method provides reliable 
results in calculating stacking energy [6, 9, 24, 65, 66], but overestimates the hydrogen 
binding energy [6, 9, 24, 65, 66]. In the S22 data set, the mean unsigned error (MUE) is 
5.54 kcal/mol for hydrogen bonded complexes, compared to 0.84 kcal/mol for dispersion-
bound complexes. Another DFT improvement is PW91 functional [67]. This method 
provides well for stacking. However, this method, similar to BHandH, fails in describing 
hydrogen-bond energy [4, 6, 9, 67].  
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Non-local van der Waals density functional (vdW-DF) was created in order to include the 
energy of van der Waals interaction in DFT calculations [68, 69]. It has been found that 
vdW-DF with semilocal functional revPBE exchange performs very well in calculating the 
van der Waals binding energy [48]. One disadvantage of this method, however, is that with 
hybrid exchange functionals it results in significant overbinding of many complexes [48], 
and that this method is rather slow, such that more work is needed in order to improve it 
[70, 71].  
 
Dispersion-corrected atom-centred potential (DCACP) is another method in the direction to 
include the dispersion energy in DFT calculations [72], which depends on the use of 
pseudopotentials [72]. DCACP is an empirical method, where the dispersion attraction 
between electrons and nuclei occurs by addition of an artificial potential which is optimized 
to provide the interaction energy. A disadvantage of this method is that it can not be used 
without pseudopotentials.  
 
DFT normally scales as N3 or N4, where N is the number of electrons in the system, such 
that calculations on large systems such as biological molecules rapidly become unfeasible. 
Linear scaling of DFT methods would be a highly desirable property, allowing application to 
much more realistic models of biological systems. Recent developments in the ONETEP 
(order-N electronic total energy package) density functional package bring this goal within 
reach [73]. Specifically designed for use on parallel computers, and with careful control of 
accuracy and errors due to approximations in the linear scaling process, [74] ONETEP 
speeds up DFT calculations to allow calculation of the energy of large systems containing 
thousands of atoms [73].  
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1.3.3 Semi-Empirical Methods: 
The need for accurate and fast methods to calculate large systems has been realized for 
more than three decades, when the use of non-empirical ab initio methods was prohibitive 
[6, 75, 76]. Dewar and Thiel introduced their first semi-empirical method (modified neglect 
of differential overlap, or MNDO) [76, 77], and the Austin Model 1 (AM1) method 
subsequently developed by “adding a stabilization Gaussian function to the MNDO core-
core interaction” [78, 79]. AM1 shows good performance in many chemical studies, and has 
been widely used since then [80]. It is available in many chemical software packages. In 
1989, Stewart improved the techniques of parameterization and published parameterized 
model 3 (PM3), which gave “lower average errors than AM1, mainly for the enthalpies of 
formation” [80-82]. PM4 and PM5 are subsequent improvements on PM3, and both present 
good performance across many areas of chemistry [80]. Semi-empirical methods perform 
well [83] in calculating covalent interactions of the main group molecules in ground states 
[6]. However, semi-empirical methods often fail in calculating the non-covalent interactions, 
especially, dispersion and hydrogen bond interaction energies [42, 80].  
 
At first, it was believed that dispersion energy is more important than hydrogen bonding [6], 
so all attention was focused on correction of dispersion. Similar to DFT-D method discussed 
above, a damped dispersion term was added to AM1 and PM3 energies, and some 
parameters of each semi-empirical method modified [6, 42, 43]. The resulting AM1-D and 
PM3-D give reliable results in predicting the interaction energy between biological systems 
with an error average 1 to 1.5 kcal/mol of the results of high-level ab initio methods [42, 43]. 
In addition, another advantage is these calculations can be carried out with same speed as 
AM1 and PM3, making them useful in calculating large biological systems [42]. Semi-
empirical methods with dispersion correction succeed in calculating dispersion energy, but 
their performance for hydrogen bond energies is limited [42, 43, 80].  
 15  
 
OMx (orthogonalization models OM1, OM2, and OM3) semi-empirical method present 
very accurate results in calculation biological systems, better than standard semi-
empirical methods due the use of orthogonalization corrections [6, 84]. With a dispersion 
term and without modification of the parameters, OMx-D methods are highly successful 
in calculation biological systems [84]. Table (1.1) shows the mean unsigned error (MUE) 
for the hydrogen bonded complexes, stacked base pairs, the S22 set, and the JSCH-
2005 set (a larger set of peptide and nucleic acid complexes) taken from [84].   
 
  AM1 OM1 OM1-D OM2 OM2-D OM3 OM3-D 
Hydrogen-bonded complexes 14.78 10.25 6.99 5.67 2.41 5.72 2.54 
stacked base pairs 10.67 6.68 1.08 6.36 1.52 6.53 1.26 
S22 7.02 5.32 2.52 3.28 1.15 3.81 1.23 
JSCH-2005 8.67 6.04 2.35 4.55 1.41 4.77 1.31 
 
Table 1.1: MUE of AM1, OMx and OMx-D for hydrogen-bonded complexes, stacked base pairs, 
S22 set, and JSCH-2005 in kcal/mol (from ref [84]). 
 
This table shows that OMx methods, even without the dispersion term, perform rather 
better than AM1. It also shows that OM3 performs better than OM2, which in turn is better 
than OM1 for all complexes. In addition, it shows that by adding a dispersion term, all 
methods results improved, especially for stacked base pairs. OM2-D and OM3-D provide 
similar results. For S22 set, the MUE for OM2-D and OM3-D are 1.15 and 1.23 kcal/mol, 
respectively. For JSCH-2005, the MUE for OM2-D and OM3-D are 1.41 and 1.31 kcal/mol, 
respectively. 
 
Self-consistent charge density functional tight-binding (SCC-DFTB) method is a semi-
empirical method based on DFT approach [85]. This approach applies a minimal valence 
basis set, and shows similar computational speed to semi-empirical methods [86]. SCC-
DFTB provides good results in calculating many biological molecules such as peptides and 
nucleic acids [87]. This method, augmented with a dispersion term (SCC-DFTB-D) is a 
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successful method in calculating non-covalent interactions. It can be used to study large 
systems with several thousands of atoms [6, 88]. It has been found that the root mean 
square error (RMSE) for hydrogen complexes from S22 benchmark set for this method is 
1.53 kcal/mol, for dispersion complexes is 0.82 kcal/mol, and for mixed complexes is 0.86 
kcal/mol [89].  
 
In 2006, RM1 (Recife Model 1) was published [78]. This is a new parameterization method 
of AM1 [78, 80, 83], and can be easily used in any software that contains AM1 [80].  The 
parameterization set of this method contains 1736 important molecules in biochemistry 
containing ten atoms (C, H, N, O, P, S, F, Cl, Br, and I) using only the s-p basis set [78, 90], 
with all parameters re-optimized [80].  RM1 method performs better than related methods, 
and is therefore widely chosen in modeling organic compounds [78], and is successful in 
studying large molecules when used with MOZYME (see below). RM1 is not just considered 
an overall improvement over AM1, but also over PM3 [80, 83, 91], and corrected a problem 
with nitrogen charge in PM3 [80].  The average error for this method comparing with AM1, 
PM3, and PM5 for calculating the enthalpies of formation, dipole moment, ionization 
potential, bond length, and angles for the all 1736 molecules comparing with reference data 
are shown in Table (1.2). It is clear that the errors of RM1 in all properties (except for the 
bond angles) is the smallest [80]. However, while RM1 improves the accuracy of calculating 
non-covalent interactions in biological systems, its results are not perfect.  
 
Properties AM1 PM3 PM5 RM1 N 
Enthalpies of formation 
(kcal/mol) 11.15 7.98 6.03 5.77 1480 
Dipole moment (D) 0.37 0.38 0.5 0.34 127 
Ionization potential (eV) 0.6 0.55 0.48 0.45 232 
Bond length (A) 0.036 0.029 0.037 0.027 904 
Angles (degree) 5.88 6.98 9.83 6.82 910 
 
Table 1.2: MUE (kcal/mol) in properties for 1736 molecules for AM1, PM3, PM5, and RM1 
taken from ref [80]. N is the number of quantities used in the comparison. 
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One drawback of RM1 method has been solved in the RM1-BH method, where BH stands 
of biological hydrogen bonding. This was achieved by adding one more Gaussian function 
to the core-core repulsive term in the semi empirical formula for atoms contributing to 
hydrogen bonds [83]. The prediction of RM1-BH for hydrogen-bond interaction energy is 
very promising when compared with the methods discussed above [83].  The MUE 
(kcal/mol) for PM3, RM1, and RM1-BH comparing with the MP2 method as a benchmark for 
35 hydrogen bonded base pairs, hydrogen bonding amino acid residues, and hydrogen 
bonding protein-nucleic acid complexes are shown in Table (1.3). 
 
Complexes PM3 RM1 RM1-BH 
Base-pair dimers 6.4 5.5 1.7 
Amino acid residue dimers 5.6 4 1.6 
Dimers between a base and 6.7 6.5 1.9 
an amino acid residue       
 
Table 1.3: MUE (kcal/mol) for PM3, RM1, and RM1-BH for 35 hydrogen bonded base pairs, 
hydrogen bonding amino acid residues, and hydrogen bonding protein-nucleic acid 
complexes (taken form ref [83]). 
 
For the base pair dimers, it is clear that PM3 and RM1 underestimate hydrogen bonding 
energy, with MUE 6.4 and 5.5 kcal/mol, respectively [83], while RM1-BH gives reliable 
results (MUE 1.7 kcal/mol) comparing with MP2 benchmark data [83]. The same conclusion 
for the amino acid residues, and protein-nucleic acid complexes, PM3 and RM1 
underestimate the hydrogen binding energy for these sets [83]. For amino acid residues set, 
the MUE for PM3 and RM1 are 5.6 and 4 kcal/mol, respectively [83]. For protein-nucleic 
acid complexes, the MUE for PM3 and RM1 are 6.7 and 6.5 kcal/mol, respectively [83]. 
From these results, it is clear that RM1-BH overall improves performance over RM1 and 
PM3 methods in calculating hydrogen bonding energies for biological molecules [83].  
 
After several incremental improvements, the most recent semi-empirical method is PM6 
(parameterized model 6), published by Stewart in 2007 [78], which has parameters for 80 
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atoms, covering most of the periodic table. PM6 is the most accurate method among the 
semi-empirical method up to date [6, 92]. It performs better than high level method such as 
HF or B3LYP DFT with 6-31G(d) basis set in calculating heats of formation [78]. For the HF 
and B3LYP set, the average unsigned errors for HF, B3LYP, and PM6 are 7.4, 5.2, and 4.4 
kcal/mol, respectively [78]. Although PM6 is the most accurate method among semi-
empirical methods, its performance in calculating non-covalent interactions, especially 
dispersion and hydrogen bonding, was not as accurate as might have been expected [6, 
78].  Even by adding a dispersion term, as in DFT, its performance for non-covalent 
interactions does not improve, as shown in Table (1.4) [93].   
 
Three generations of correction for hydrogen bonds have been published: PM6-DH1, PM6-
DH2, and PM6-DH+ [92-94]. These methods contain two correction terms, one for 
dispersion and one for specific hydrogen bond interactions [6]. The first generation 
correction (PM6-DH1) was successful in calculating dispersion energy, but for hydrogen 
bond energy the performance was disappointing [6].  Although PM6-DH1 approach shows a 
large improvement in studying hydrogen bond energy and opened a new path in hydrogen 
bond corrections[93], it suffers some problems [92-94]. These problems were solved in the 
second generation of the hydrogen bond correction PM6-DH2 [93, 94]. This method  
succeeds in calculating hydrogen bond energies with accuracy close to DFT-D approach, 
but is three orders of magnitude faster [93, 94].  A disadvantage of this method is that it fails 
when the acceptor atom changes, such as the case in proton transfer [92-94]. PM6-DH+ 
solves the drawbacks of the first and second generations of the correction with very close 
accuracy to PM6-DH2, as shown in Table (1.4) [92-94], and also solving the limitations of 
PM6-DH2 for proton transfer.  
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Complexes PM6-D PM6-DH2 PM6-DH+ 
H-bonded complexes from S26 set 3.56 0.27 0.88 
H-bonded complexes from JSCH2005 set 6.3 2.23 1.59 
 
Table 1.4: RMSE (kcal/mol) for PM6-D, PM6-DH2, and PM6-DH+ for H-bonded complexes from 
S26 and JSCH2005 sets taken from [93]. 
 
 
The RMSE for H-bonded complexes from S26 and JSCH2005 benchmark data set for PM6-
D, PM6-DH2, and PM6-DH+ are shown in table (1.4).  From these results, it is clear that 
adding a dispersion term to PM6 does not improve results for hydrogen-bonding 
interactions. Improvement for hydrogen-bonding interactions is achieved by adding the 
hydrogen correction as mentioned above. For the H-bonded complexes from S26, the 
RMSE errors are 0.27 and 0.88 kcal/mol for PM6-DH2 and PM6-DH+, respectively, i.e. both 
methods perform very well. From these results, it is evident that PM6-DH2 performs better 
than PM6-DH+. This is because the S22 set was used to parameterize this method, so this 
accuracy does not reach beyond this set. This is clear in the results for hydrogen-bonding 
complexes from JSCH2005 set. The RMSE errors are 1.59 kcal/mol for PM6-DH+ and 2.23 
kcal/mol for PM6-DH2 approach.   
 
The applicability of semi-empirical methods to large systems is further enhanced by the 
MOZYME method implemented in current versions of MOPAC [95]. PM6 with MOZYME 
can be used to calculate large systems [78]. MOZYME uses localized molecular orbital 
instead of the standard SCF procedure [78, 95]. 
 
1.3.4 Basis Set Superposition Error and Perturbation Theory: 
All the supermolecular approaches discussed above suffer to some extent from basis set 
superposition error (BSSE). The interaction energy can be calculated using eq (1.3) only 
when infinite basis set is used:  
∆E= ∆E R-T + (ER –ET)        (1.3) 
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With finite basis sets, the supermolecular calculation on the complex uses all basis 
functions of all subsystems, whereas calculations on constituent monomers do not. This 
leads to better but non-physical description of the complex than of the monomers, and the 
error is called BSSE [4]. To solve this error, the counterpoise procedure of Boys and 
Bernardi may be applied [96], in which each monomer is calculated in the full complex basis 
set. BSSE becomes smaller by using expanded basis sets, and the error typically becomes 
negligible by using extended basis set such as cc-pVQZ [4]. It has also been shown [21] 
that use of augmented, diffuse functions on hydrogen atoms exacerbates BSSE, such that 
a basis set consisting of aug-cc-pVnZ on heavy atoms and cc-pVnZ on hydrogen can 
reduce BSSE with little or no reduction in accuracy. BSSE is generally larger in correlated 
ab initio methods than in Hartree-Fock or DFT approaches, as the former depend on virtual 
as well as occupied orbitals, which are often much more diffuse. One exception to this 
general rule is local correlation methods, where restriction to spatially close virtual orbitals 
reduces BSSE to negligible levels [21]. Semi-empirical methods are not thought to suffer 
significantly from BSSE, since spatially restricted minimal basis sets are usually employed. 
 
An alternative to the supermolecular approach to calculation of non-covalent interaction 
energies is symmetry adapted perturbation theory (SAPT) [15, 89, 97]. This is a highly 
accurate method to calculate the interaction energy directly without the disadvantages of 
BSSE [89]. The interaction energy is calculated as the sum of first-order (electrostatic and 
exchange energies), second-order (induction and dispersion energies), and higher-order 
(charge transfer energy) contributions. While it is highly accurate, the computational cost of 
a standard SAPT approach is comparable to CCSD(T), and so is only applicable to small 
model systems. [4, 15, 97]. 
 
 21  
Further success has been gained by using a combination of SAPT and DFT methods with 
extended basis sets [89, 98-107]. The method becomes able to calculate molecules such 
as benzene dimer and DNA base pairs [101, 106]. This (DFT)SAPT method, also known as 
SAPT-DFT, calculates the interaction energy as eq (1.4) 
 
E int= E1 pol + E1 ex + E2ind + E2 ex-ind + E2disp + E2 ex-disp + δ (HF)     (1.4) 
 
E1 pol + E1 ex are the first order contributions, and include electrostatic (polarization) and 
exchange components. E2ind + E2disp are the second order contributions, which contain 
induction and dispersion components. E2 ex-ind and E2 ex-disp are the exchange counterparts 
of the induction and dispersion. Higher-order contributions are replaced with δ (HF), which 
allows this method to calculate intra-molecular correlation in DFT level, while the inter-
molecular interaction treated in SAPT method [4].  
 
1.3.5 Atomistic force fields: 
Atomistic force fields are widely used in simulation of biological systems by reducing the 
essentials of systems of interest to simple mathematical forms based on Newtonian 
mechanics. Non-covalent interactions are typically treated by a combination of point 
charges, to account for electrostatics, and Lennard-Jones potentials, for dispersive and 
repulsive interactions [108]-[109].  More than a decade ago, Hobza et al showed that the 
force field of Cornell et al (often referred to as AMBER) best reproduced ab initio data for 
interaction of DNA base pairs [108]. More recently, Paton and Goodman showed that the 
OPLS-AA force field performs well for binding energy prediction of both hydrogen bonding 
and dispersion-bound complexes [109].  
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The generalized Born model/surface area approach (GB/SA) is another method used to 
calculate binding free energy, developed by Still et al [110-112], and is widely used in 
calculating free energy of binding for ligand-receptor complexes [113-115]. In this method, 
cavitation energy depends on molecular surface area, while relative solvation of separated 
ligand and receptor compared to their complex is estimated from a generalization of the 
Born model. When combined with MM methods for calculation of electrostatic and van der 
Waals interactions, these are referred to as MM-GB/SA methods. The GB/VI (generalized 
Born/volume integral) model, implemented in recent versions of MOE software [116], is 
similar to GB/SA in most respects, but calculates the cavitation energy as an integral over 
molecular volume rather than surface area [112]. MM/GB-VI is a fast and promising method 
to calculate the interaction energy in solvent. There are many advantages of using this 
method, the dielectric constant of the solvent is estimated based on the atoms [116] present 
in the specific complex under study, rather than on  idealised values. In addition, this 
method yields an estimate of binding free energy, unlike all other methods used here that 
give only interaction energies. The change in entropy on binding is not explicitly included in 
MM/GB-VI: it has previously been shown that although entropy is essential in calculating 
absolute binding free energy [114]. it is not essential for estimating the relative binding free 
energy[117, 118]. 
 
1.3.6 Implicit and explicit solvation models:  
Solvent can have an important influence on the structure and properties of biomolecules, so 
in many cases one must consider the effect of solvent in calculations. There are two main 
methods to predict the solvation effect on biomolecular properties, [119-121] namely implicit 
(or continuum) and explicit solvation models. Explicit solvent models include the solvent 
molecule explicitly in the calculation, while the implicit solvent models replace the solvent 
molecules with a dielectric continuum or similar medium [122, 123]. Each method has its 
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advantages and disadvantages: while explicit solvent models consider the solvent effect in 
the highest levels of detail, they can be expensive and time consuming. On the other hand, 
implicit solvation models are able to ‘‘pre-average’’ solvent effect and therefore reduce the 
need for computationally expensive sampling, making these model widely used in studying 
biomolecules [124]. Conductor-like Screening Model (COSMO) is a continuum method 
which is widely used to model solvents, especially water [113, 125, 126]. This method 
depends on generation of a conducting surface at vdW distance in order to calculate the 
dielectric screening charges and energies [125].  
 
There are, however, some major disadvantages of implicit models, which cannot treat the 
effect of hydrogen bond between solvent and solute [127, 128]. According to Suhai et al, 
continuum solvation models do not provide the correct geometry of some simple biological 
molecules such as alanine dipeptide, while explicit models do.  Because both models 
(implicit and explicit) have their strengths and weaknesses, a combination of both methods 
were used by Chalmet et al [129]. In this approach, the first shell of the solvent, which has 
different effect on the solute from the bulk, was treated explicitly while the remainder was 
treated as continuum model.  However, it has been found that such mixed solvent models 
do not necessarily give more accurate performance than either pure implicit or explicit 
models [130].  
 
 
 
 
 
 
 
 24  
1.4 Conclusions 
Methodological developments, coupled with ever-improving computer hardware, mean that 
theoretical methods are increasingly used to probe the non-covalent interactions in 
biological molecules. Benchmark ab initio methods, as well as those based around 
intermolecular perturbation theory, can still only be applied to relatively small model 
systems, but new theoretical developments mean that applicability is always increasing. 
Density functional theory requires less computational resources, but only recently have 
such methods been able to properly balance the importance of electrostatic and dispersion-
based interactions. Semi-empirical methods, especially when used together with empirical 
dispersion and/or hydrogen bonding corrections, and force field  methods show much 
promise for treatment of entire proteins or nucleic acids.  
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In this chapter, a brief theoretical background of the methods that were used in this 
work is presented. Several textbooks [1-10] were used as main references, unless 
otherwise cited. 
 
2.1 Schrödinger equation: 
The time-independent Schrödinger equation is the foundation of Quantum 
Mechanics theory: 
�����          (2.1) 
 
It is a second order partial differential equation. H is the Hamiltonian operator, Ψ is 
a wavefunction, and E is the energy of the system. This eigenvalue equation can 
be solved by knowing the function Ψ and the eigenvalue E.   
 
The Hamilton operator includes five contributions to the total energy of a system: 
the kinetic energies of the electrons and nuclei, the attraction of the electrons to 
the nuclei, and the interelectronic and internuclear repulsions. 
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i and j are electrons, k and l are nuclei, ħ is Planck’s constant divided by 2� , me is 
the mass of the electron, mk is the mass of nucleus k, e is the charge on the 
electron, Z is an atomic number, rkl  is the distance between k and l nuclei, and 
2� is the Laplacian operator: 
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Where x, y, and z are Cartesian coordinates.  
 
The Hamilton operator consists of the kinetic energy and potential energy parts. 
The first two components of (2.2) are the kinetic energy part where the last three 
components of (2.2) are the potential energy part.   
 
It is impossible to solve the Schrödinger equation for three or more particles 
because of the correlated motions of particles, so approximations are needed. The 
Born-Oppenheimer approximation is used to solve Schrödinger equation for many 
body systems.  
 
2.2 Born-Oppenheimer Approximation: 
The idea of this approximation is that the nuclei of molecular systems are moving 
very slowly compared to electrons: therefore; the nuclei can be considered to be 
fixed with respect to electrons motion and the electrons depend on any changes on 
the positions of the nuclei. This difference on the motions is due to the great 
difference in masses between electrons and nuclei. On this approach, the nuclear 
kinetic energy is neglected and the nuclear-nuclear repulsion is considered a 
constant, and the Schrödinger equation is solved for the electrons alone in the 
electrostatic field of the nuclei. The electronic Hamiltonian includes the first, third 
and fourth contributions of eq (2.2):  
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The total wavefunction for the molecular system ),( Rrtotal�  can be divided into an 
electronic wavefunction ),( Rrelectrons�  and a nuclear wavefunction ),( Rrnuclei� : 
 
),(),(),( RrRrRr nucleielectronstotal ����       (2.5) 
Where r is electronic coordinates and R is nuclear coordinates.  
 
The electronic Schrödinger equation is: 
),(),( RrRr elecelecelecelec �����        (2.6) 
Where the electronic coordinates r are independent variables and the nuclear 
coordinates R are parameters.  
 
2.3 Hartree - Fock Approximation:  
Hartree - Fock method is an approximation to solve Schrödinger equation for 
many-body system. It depends on the one-electron Fock operator )(if in which the 
electron-electron repulsion is presented in an average potential )(iU HF  , in which 
the single electron (i) has been affected by all the rest of the electrons.  
 
)(2
1)( 2 iU
r
Zif HF
k ik
k
i ����� �         (2.7) 
Because the solution of one electron affects the other electrons by the average 
potential term, the Hartree – Fock equation (2.8) need to be solved by Self-
consistent Field method (SCF).  
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)()()( ii xxif ��� �     (2.8) 
The main disadvantage of this method is that it ignores electron correlation due to 
the electron-electron repulsion, which is treated as an average, so it does not 
provide the exact energy exactE : 
HFexactcor EEE ��      (2.9) 
 
corE is the correlation energy, which is the difference between the exact energy 
exactE  and HF energy HFE . It is an important term on calculating chemical 
properties.  
 
Based on Hartree - Fock method many methods had been developed such as 
Coupled Cluster (CC), Møller–Plesset Perturbation Theory (MPPT), and Density 
Functional Theory (DFT). 
 
2.4 Coupled Cluster (CC): 
One of the best methods to calculate the electron correlation energy is coupled 
cluster method (CC). It is a size-consistent method, i.e. that the energy of two 
atoms or molecules at infinite separation equals the sum of the energy of each 
atom or molecule. On this method the full-correlation interaction wavefunction is 
included, and writing as: 
 
HF
C
CC e ���       (2.10) 
 
The cluster operator C is defined as: 
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������� in CCCCCC ...........321      (2.11) 
Where n  is the total number of electrons, and i  is the excitation level.  
 
The coupled cluster is a computationally expensive method; therefore other more 
economic schemes are used instead such as coupled cluster with double-
excitation operator CCD where C is approximated as ( 2CC � ), coupled cluster with 
single and double-excitation operator CCSD where C is approximated as 
( 21 CCC �� ). Coupled cluster with single, double and triple-excitation operator 
CCSDT where C is approximated as ( 321 CCCC ��� ), which is highly accurate 
but very computationally expensive and so only applicable to small model systems.  
 
The CCSD(T) approach, in which triple excitations are included perturbatively, 
provides almost identical accuracy to CCSDT method with much reduced 
computational cost. CCSD(T) method is now widely known as the “gold standard” 
of single-reference calculations [11]. 
  
2.5  Møller–Plesset Perturbation Theory (MPPT): 
Møller–Plesset presented an alternative theory to solve the problem of electron 
correlation. MPPT method is a size-consistent method and it is based on the 
perturbation theory. The Hamiltonian H of a system includes the sum of a zeroth-
order Hamiltonian 0H and a perturbationV : 
 
VHH ��� 0     (2.12) 
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Where � is a parameter that has a value between 0 and 1. When �  is zero then 
H  is equal to 0H , but if �  is 1 then the H  equals to its true value.  
The eigenfunctions i� and the eigenvalues iE of the Hamiltonian H  are expressed 
in power of� : 
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iE is the first-order correction to the energy, )2(iE is the second-order correction 
and so on. From the eigenfunction, the energies can be calculated as: 
�dHE iii )0(0)0()0( ��� �       (2.13) 
�dVE iii )0()0()1( ��� �       (2.14) 
�dVE iii )1()0()2( ��� �     (2.15) 
�dVE iii )2()0()3( ��� �    (2.16) 
 
The above equations show that in order to obtain an improvement on the Hartree-
Fock energy, second-order Møller–Plesset perturbation (MP2) is required. Third-
order and fourth-order Møller–Plesset perturbation (MP3) and (MP4) are also 
available.  
 
MPPT is an ab initio method which provides low computational cost, but it is limited 
to small systems. In addition, while it provides accurate binding energies for 
hydrogen bonds it is known to overestimate the interaction energy in stacked 
systems. In order to improve the performance of MP2 and reduce the cost, many 
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methods have been developed such as density-fitted local MP2 (DF-LMP2) [12], 
which makes use of the local nature of electron correlation. Spin-component scaled 
MP2 (SCS-MP2) [13], which depends on separation of the correlation energy 
resulting from anti-parallel and parallel spin pairs of electrons, and assigns two 
new scaling factors to these contributions. Spin-component scaled for nucleobases 
(SCSN) was developed by optimising the scaling factors against binding energy of 
stacked nucleobases, and totally neglects the anti-parallel-spin electron pairs 
contribution and gives the parallel spin contribution a scaling of 1.76 [14]. SCS-
MP2 for molecular interactions (SCS(MI)-MP2) is an improvement of SCS-MP2 
approach [15, 16]. In this method the parallel-spin contribution and anti-parallel 
spin contribution scaled 1.29 and 0.40, respectively [16].  
 
2.6  Density Functional Theory (DFT): 
All ab initio methods discussed above are computationally expensive and can be 
used for small molecules or clusters. The main difference between these methods 
and density functional theory is that DFT calculates the electronic density 
distribution instead of wavefunction. Density functional theory (DFT) is a very 
popular method for many reasons such as; it takes in account the electron 
correlation, it is less expensive than the ab initio methods; therefore it can be used 
to calculate molecules with 100 atoms or above, and in general it provides very 
accurate results.  
 
DFT approach calculates the energy of a system (E) as a functional of the density. 
The first model was developed by Thomas-Fermi which contains some basic 
elements. However the main theorems that underpin modern DFT were set out by 
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Hohenberg and Kohn. The first theorem is that the ground state energy of an 
electronic system is written as a functional of the electron density. In other words, 
in order to calculate the ground state energy and other property of a system, we 
only need to know the electron density in three-dimensional space and not the full 
wavefunction. That means that the energy of a system ( E ) is a function of the 
density )(rp :  
 
)]([)()()]([ rpFdrrprVrpE ext �� �     (2.17) 
 
The first term presents the interaction of the electrons with the external 
potential )(rVext . )]([ rpF  includes the kinetic energy of the electrons and the 
interelectronic interactions.  
 
The second theorem gives a variation principle for the density functionals: 
 
)]([)]([ 0 rprp elel �� �     (2.18) 
 
0p is the true density for the system and p  any other density obeying 
 
Ndtrpdtrp ��� � )()( 0    (2.19) 
 
The drawback of these theorems is that )]([ rpF  is not known. Therefore E  is 
depending on )(rp  which is also not known. 
 
The above problem was solved by Kohn and Sham approach. On this 
approach, )]([ rpF  is approximated as the sum of three terms: 
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)]([)]([)]([)]([ rpErpErpErpF XCHKE ���      (2.20) 
 
Where )]([ rpEKE  is the kinetic energy, )]([ rpEH is the electron-electron Coulombic 
energy, and )]([ rpEXC  is the exchange and correlation. )]([ rpEKE  is the kinetic 
energy of a system non-interacting electrons with the same density as the real 
system. The full expression of the Kohn-Sham is: 
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Kohn and Sham presented the density )(rp  of the system as “the sum of the 
square moduli of a set of one-electron orthonormal orbitals” [8]:  
2
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This leads to the one-electron Kohn-Sham equation: 
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][ 1rVXC is the exchange-correlation functional and i� are orbital energies. 
 
2.7 Semi-empirical methods (SE): 
Due to the extremely expensive cost of the ab initio methods and the limitation of 
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these methods, semi-empirical methods have been developed. Semi-empirical 
methods are approximation methods based on the Hartree-Fock theory. In these 
methods only the valence electrons of a system are considered explicitly, and the 
Coulomb and exchange integrals that form the most expensive part of ab initio 
methods are replaced by one or more parameters. The first semi-empirical method 
was CNDO (Complete Neglect of Differential Overlap) and the parameters were 
developed from ab initio calculations. Many approaches have been developed after 
CNDO approach, such as INDO (Intermediate Neglect of Differential Overlap), 
NDDO (Neglect of Diatomic Differential Overlap), and MNDO (Modified Neglect of 
Diatomic Overlap).  
 
2.7.1 Austin model 1 (AM1): 
Since MNDO method preformed very poorly in the prediction of hydrogen bond 
energies and geometries, Dewar and co-workers presented the Austin Model 1 
(AM1) semi-empirical method. The main modification was done on the nuclear 
repulsion term by “adding a stabilization Gaussian function to the MNDO core-core 
interaction”[17, 18]. On AM1 the nuclear repulsion energy between nuclei A and B 
is written as: 
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Up to 4 parameters for each atom a, b, and c presented Gaussian functions. In the 
beginning this method described just four elements C, H, O and N and then 
parameterization for B, F, Mg, Al, Si, P, S, Cl, Zn, Ge, Br, Sn, I, and Hg have been 
presented.  
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2.7.2 Parameterized model 3 (PM3): 
Parameterized model 3 (PM3), which is also based on MNDO approach, was 
developed by Stewart by improving the techniques of the parameterization. It has 
parameters for H, C, N, O, F, Al, Si, P, S, Cl, Br, and I in the beginning but later 
parameters for Li, Be, Na, Mg, Ca, Zn, Ge, As, Se, Cd, In, Sn, Sb, Te, Hg, Tl, Pb, 
and Bi have been added. PM3 has two Gaussian functions for each atom instead 
of four in AM1.  
 
2.7.3 Recife Model 1 (RM1): 
Recife Model 1 (RM1) is a new parameterization method of AM1 [17], and can be 
easily used in any software that contains AM1. The parameterization set of this 
method contains 1736 important molecules in biochemistry containing ten atoms 
(C, H, N, O, P, S, F, Cl, Br, and I) using only the s-p basis set with all parameters 
re-optimized [17, 19]. 
 
2.7.4 Parameterized model 6 (PM6): 
Parameterized model 6 (PM6) was developed by Stewart [17]. PM6 has 
parameters for 80 atoms, covering most of the periodic table. PM6 is the most 
accurate method among the semi-empirical method up to date.  
 
2.7.5 MOZYME: 
MOZYME is MOPAC keyword which uses localized molecular orbital (LMO) 
instead of the standard SCF procedure. 
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2.8 Force Field (FF) methods: Molecular Mechanics (MM): 
The energy of a molecule in the force field (FF) methods is calculated as a function 
of the nuclear positions only. On these methods, the electronic motion is 
completely neglected.  
 
The FF energy FFE  includes bonded bondE and non-bonded bondnonE � energies. The 
bonded energy contains the bond stretching energy, the bond angle energy and 
the bond rotation (torsion) energy. The non-bonded energy contains the van der 
Waals and electrostatic energies.    
bondnonbondFF EEE ���      (2.25) 
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Where ik and nV are the force constants. il  and i� are the bond length and the 
valence angle deviate from the reference values 0,il  and 0,i�  respectively. �  is the 
phase angle. ijr is the distance between atom i and j. ij�  and ij�  are Lennard-
Jones parameters. iq and jq are the atomic charges on atom i and j.  
 
2.8.1 AMBER: 
Assisted Model Building with Energy Refinement (AMBER) is a force field method 
developed by Kollman for the simulation of peptides and nucleic acids. In this 
method hydrogen bonding was described explicitly with a 12-10 potential: 
)( 10101212 R
C
R
CU
bondsH
H �� �
�
     (2.27) 
AMBER-94 is very popular method and it is all-atom force field.  
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2.8.2 OPLS: 
Optimised Potentials for Liquid Simulations is a force field method developed to 
model proteins in solution. Many OPLS parameters have been presented to many 
atoms. OPLS-AA method includes all atoms explicitly, which was developed by 
William L. Jorgensen [20]. The parameters of the bending and bond stretching are 
based on AMBER force field [21] except alkane parameters which have been 
developed by CHARMM.  Where most torsional parameters are based on HF/6-
31G* calculations [22, 23].  
 
2.9 Continuum Solvation Free Energy:  
Solvation free energy ( SolG� ) is “the free energy change to transfer a molecule 
from vacuum to solvent.” [8] 
cavvdwelecSol GGGG �������            (2.28) 
The solvation free energy is divided to three components. First, the electrostatic 
components ( elecG� ) which is important especially for charged and polar solutes 
because of the polarisation of the solvent.  Second the van der Waals interaction 
between the solvent and solute ( vdwG� ), which is divided to the dispersion term 
( dispG� ) and the repulsive term ( repG� ). The third component of the solvation free 
energy is the cavity free energy ( cavG� ), which “is the energy required to form the 
solute cavity within the solvent.”[8] 
 
2.9.1 The electrostatic contribution to the free energy solvation: The Born and 
Onsager models: 
Born and then Onsager contributed to the study of the solvation. Born obtained the 
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electrostatic term of the solvation free energy by placing a charge within a 
spherical cavity, and this was extended by Onsager to a dipole in a spherical 
cavity. The Born model can be defined as the work needed to transfer an ion from 
vacuum to medium, and can be written as: 
 
)11(2
2
����� a
qGelec      (2.29) 
Where q is the charge on the ion, a is the radius of the cavity, and � is the dielectric 
constant. 
 
The Conductor-like Screening Model (COSMO) is a continuum approach which 
depends on generation of a conducting surface at vdW distance in order to 
calculate the dielectric screening charges and energies by providing a� -dependent 
correction factor:  
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Where �  is the dielectric constant of the solvation.  
 
Generalized Born model (GB) is widely used to calculate the electrostatic 
contribution to the solvation free energy in force field methods. The model includes 
a system of particles with radii ia and charges iq .  The total electrostatic free energy 
for a system can be calculated by taking the sum of the Coulomb energy and the 
Born free energy of solvation in a medium of relative permittivity� :  
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Where the first term in (2.31) can be written as: 
������
� ��������
��� N
i ij
jiN
ij
N
ij ij
jiN
i
N
ij ij
jiN
i r
qq
r
qq
r
qq
1 11111
)11( ��    (2.32) 
Which is the sum of the Coulomb interaction in vacuo and in )11( �� .  
The total electrostatic energy in the GB model includes three terms and the first 
term is the Coulomb interaction between charges in vacuo: 
 
�����
�������
����� N
i i
i
N
ij ij
jiN
i
N
ij ij
jiN
i
elec
a
q
r
qq
r
qq
G
1
2
1111
)11(2
1)11( ��      (2.33) 
The GB equation elecG� is the difference between elecG and the Coulomb energy in 
vacuo: 
 
���
����
������ N
i i
i
N
ij ij
jiN
i
elec
a
q
r
qq
G
1
2
11
)11(2
1)11( ��       (2.34) 
 
GB is very important method on continuum solvent calculation due to its accuracy 
(it has good agreement with experiments), simplicity and has atomic forces 
required for molecular dynamic simulations. This model is widely used on 
molecular mechanics and semi-empirical quantum mechanics calculations.  
 
2.9.2 The non-electrostatic contribution to the solvation free energy:  
The electrostatic component of the solvation free energy has been discussed 
above. The other two components: the van der Waals and the cavity free energy 
are usually combined to:  
bAGG vdwcav ����� �      (2.35) 
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Where A is the total solvent accessible area and �  and b  are constants. The 
constant b is commonly set to 0, making the cavity and van der Waals terms 
depended on the solvent accessible area.  
 
2.9.2.1 Generalized Born Surface Area (GB-SA): 
Generalized Born model Surface Area (GB-SA) is widely used in calculation the 
solvation free energy of a solute solE  as a sum of polarization and cavitation terms: 
 
cavpolsolsol EEEG ����     (2.36) 
polE  is a classical electrostatic term which presents the induced charge interactions 
between the solute and solvent, and cavE  presents the non-classical effects, solute-
solvent van der Waals interactions and the energy necessary for creating the 
solute cavity in the solvent. The polE  can be written as:  
),;(42
1
0
11
1 eff
j
eff
iij
ij
GBjipol RRrFqqE ��� ��� ����     (2.37) 
 
ijr is the distance between atoms i and j , iq  is the partial charge of atom i , 1� is 
the dielectric constant of solute interior, � is the dielectric constant of the solvent, 
0� is the vacuum permittivity, effiR is a position only dependent effective Born radius 
of atom i  which presents the degree of which the atom is buried, and GBF  is a 
pairwise interaction function presented by Still.  
 
)(1);( 2 jiijGB
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iijGB GGrS
r
GjGrF �     (2.38) 
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Where )2(
1
eff
i
i R
G ��  and 2
1
11 )4/1()(
�
���� ettSGB . By using these values the (2.37) 
equation is written as: 
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��      (2.39) 
{}{ iG } are the Born self energy factors of the individual atoms placed in the solute 
cavity.  
In GB-SA model, the cavity term cavE is a linear combination of exposed atomic 
surface areas: 
i
i
icav AE �� �     (2.40) 
Where iA is presents the exposed surface area of atom i . And { i� } are a 
coefficients dependent on the chemical type of each atom. 
 
2.9.2.2 Generalized Born Volume Integral (GB-VI): 
In this method [24] the cavitation term cavE is calculated by solvent volume integral 
3)2( iiGR  instead of solvent exposed surface area as on GB-SA: 
})2(4
(
4{}{
3
10
2
1 0
2
ii
n
i
i
n
ji ij
jiijGBjin
i
ii
VIGB GR
r
GGrSqqGq
E ���
���
� ��� ������     (2.41) 
Where )( 111 �� �� ��� , 2/11 )4/1()( ����� tGB ettS and        
xdsolutexrRGR iii
3663 )(4
3)2( ��� ��� � ��   (2.42) 
The partial charge iq must be specified, { iR } and { i� } are parameters that must be 
estimated from experiment.  
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2.10  Molecular Dynamic (MD):  
Molecular dynamic simulation solves the numerical integration of Newton's 
equations (F= ma) of motion for a system for a period of time. The velocities and 
trajectories for the system on this period of time are saved. Many properties can be 
evaluated using these trajectories. MD starts by giving each atom on the system 
some kinetic energy. The force )(tFi  eq (2.43) on atom i  can be calculated by the 
potential energy function based on its position )(tri : 
 
,....)(...., i
i
i rv
r
F �
���  (2.43) 
The acceleration )(tai of this atom is: 
i
i
i
m
tF
ta
)()( �     (2.44) 
The atomic position can be obtained by: 
i
ii
m
tF
t
dr
rd )()(2
2
�    (2.45) 
For each atom there are three components: 
)()( tftam
j
ijii ��    (2.46) 
Where )(tf
j
ij� is the sum over all atoms j presenting forces on atom i which need 
to be calculated. In order to do so, it is replaced with difference equations for a 
small time step which can be solved successfully by Taylor series approximations: 
2)()()()(
2r
tattvtxttx iiii
�������   (2.47) 
2)()()()(
2r
tattvtxttx iiii
�������    (2.48) 
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Where x is the coordinate of atom i.  By adding the two equations (2.47) and 
(2.48):  
2)()()(2)( ttattxtxttx iiii ��������    (2.49) 
And by substitution from (2.45): 
��������
j i
ij
iii
m
tf
ttxtxttx
)()()(2)(     (2.50) 
This equation above gives the prediction of the position of atom i at time tt ��  if 
we know the position at time t and tt �� . This equation is known as the Verlet 
algorithm and it is used to find the position of each atom at time steps. 
By subtracting equations (2.47) and (2.48): 
 
t
ttxttx
tv iii �
������ 2
)()()(     (2.51) 
Where )(tvi is the velocity at time t.  
 
2.10.1 Assisted Model Building with Energy Refinement (AMBER): 
Assisted Model Building with Energy Refinement (AMBER) is a collection of 
programs is widely used to study molecular dynamic simulations and to analyze 
the results for proteins, nucleic acids and carbohydrates. The calculations are 
divided in to three stages; preparation, simulation and analyzing the output files. 
Each stage has been done by one or more of AMBER programs. The preparation 
was done by LEaP program, the simulations by Sander, and the analyzing by Ptraj 
and MM/(PB)GBSA methods.   
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2.10.2 MM/PB(GB)SA: 
Molecular Mechanics Poisson-Boltzmann Surface Area (MM/PBSA) and Molecular 
Mechanics-Generalized Born Surface Area (MM/GBSA) methods are widely used 
to calculate protein-ligand binding free energy. In these methods the binding free 
energy ∆G Bind, Solv calculated by the sum of gas-phase (vacuum) contribution ∆G 
Bind, Vacuum, desolvation free energy of the system ∆Gdesolv and entropic contribution -
T∆S (see equation 2.52 and Figure 2.1).  
 
∆Gbind = ∆G Bind, Vacuum  + ∆Gdesolv -T∆S            (2.52) 
 
The vacuum term ∆G Bind, Vacuum includes the van der Waals interaction energy 
∆GvdW , the electrostatic interaction energy ∆Gelec , and the internal energy variation 
between the two molecules on the complex ∆Gintra  (bond, angle, and torsional 
angle energies) between the complex and isolated molecules: 
 
Sander: 
  Run simulations and save production trajectory 
 
LEaP: 
 Prepare input parameter and topology file 
 
Ptraj and MM/PB(GB)SA: 
Analyze output and trajectory files 
 
prepare input 
  PDB File 
AMBER 
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∆G Bind, Vacuum= ∆GvdW+ ∆Gelec+ ∆Gintra              (2.53) 
 
 
∆Gdesolv is the difference between the solvation free energy ∆G solv, Complex of the 
complex and of the isolated part (∆G solv, Ligand and ∆G solv, Receptor): 
 
∆Gdesolv = ∆G solv, Complex - (∆G solv, Ligand +∆G solv, Receptor )    (2.54) 
 
 
The solvation free energy includes the electrostatic ∆Gelec.solv and the nonpolar 
contributions ∆Gnp.solv.  
 
∆Gsolv  =∆Gelec.solv + ∆Gnp.solv             (2.55) 
 
The vacuum component ∆G Bind, Vacuum is calculated by single point energy 
calculations, while the solvation components ∆G solv, Complex ,∆G solv, Ligand  and ∆G solv, 
Receptor )  are calculated by Poisson-Boltzmann (PB) equation on MM/PBSA, or by 
Generalized Born (GB) equation on MM/GBSA method which has been found 
much faster than MM/PBSA . 
 
The entropy component divided to translational Strans, rotational Srot and vibrational 
Svib.  Because of the expensive cost of calculating of the entropy term and the 
chance of errors, MM-PB (GB)SA method may neglect the entropy contribution 
especially when “a comparison of states of similar entropy is desired such as two 
ligands binding to the same protein” [25] 
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Figure 2.1: Thermodynamic cycle used on MM/PB (GB)SA calculations, black 
surfaces indicate vacuum and the blue surfaces indicate solvent.  
 
2.11 Statistical methods:  
Spearman’s rank correlation ( sr ) is a statistical method which evaluates the 
strength link between two sets ( X  andY ): 
 
)1(
61 2
2
���
�
nn
d
rs      (2.56) 
 It starts by ranking these sets starting from 1 for the smallest value for each set 
( xrank ) and ( yrank ). 2d is the difference between the two ranks and n is the 
number of data pairs. If the value of sr  is 1 or -1, it means that there is a perfect 
correlation between these two sets. If sr  is equal to 0, there is no correlation.  
 
The Pearson correlation coefficient (r) is similar to Spearman’s rank correlation 
[26]. It evaluates the linear relation between two x and y: 
∆G° solv, Ligand ∆G° solv, Receptor ∆G° solv, Complex 
∆G° Bind, Solv 
∆G° Bind, Vacuum 
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r     (2.57) 
n is the number of data pairs. r =1 or -1 means perfect correlation (positive and 
negative correlation, respectively. r =0 means there is no correlation between 
these two sets.  
 
Coefficient of Determination (R2 or r2) estimates the strength of the linear 
correlation between x and y. It takes a value between 0 and 1. Another definition of 
the Coefficient of Determination is that it gives the percent of the variance in data 
that is explained by the best fitted line.  For example, R2 =0.85 means that 85% of 
the data are accounted for by the model.  
 
Receiver operating characteristic (ROC) curve is a technique which evaluates a 
method that predicts positive and negative results [27, 28] for example by using a 
cutoff. It is important to have information about when the results can be considered 
positive or negative, for example a cutoff has been used in this work. In order to 
get ROC curve, the specificity (Sp) and sensitivity (Se) of the data set must be 
calculated:  
 
Specificity (Sp) = Number of true positives / Number of peptides in positive test set 
and 
Sensitivity (Se) = Number of true negatives / Number of peptides in negative test 
set. 
 
A ROC curve can be achieved by plotting specificity against sensitivity for a range 
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of values, calculated by for example the cutoff. The accuracy of the method is 
calculated by measuring the area under the ROC curve (a). a may take a value 
between 1 and 0.5. a=1 means a perfect prediction, where a=0.5 means a random 
prediction.  
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Chapter 3: 
Ab initio, DFT and semi-empirical calculations of Myelin Basic Protein epitope (MBP) 
to MHC class II: 
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3.1 Introduction: 
 
In order to create and develop new drugs, we have to understand the way that a drug 
interacts with its receptor in order to affect the biological system in the body's cells. One 
important concept is understanding the chemical interactions between the drug and the 
receptor.[1-3] In most cases, the most significant interactions between drugs and their 
biological receptors are non-covalent interactions.[4] Although, non-covalent interactions 
are typically weaker than covalent interactions, collectively they exert an important influence 
in many properties of biomacromolecules, for example they are well known to affect the 
structure of proteins, DNA and RNA.[5-8]   
 
Biomacromolecules are very large systems. Because of their size [9], and their flexibility [4, 
10], there are many difficulties to use some of the computational methods to study the non-
covalent interactions. Empirical potentials, Semi-empirical quantum chemical methods, and 
ab initio HF methods have been used to investigate the non-covalent interactions in 
biomacromolecules [11]. We have employed many of the methods discussed above to 
examine in detail the interaction of the immuno-dominant epitope of myelin basic protein 
(MBP) with Major Histocompatibility Complex (MHC) class II receptor.  
 
 
3.1.1 Myelin Basic Protein (MBP): 
Myelin Basic Protein (MBP) contributes in the myelination (i.e. formation of an insulating 
sheath) of nerves in the central nervous system (CNS) [12, 13]. It has been found that MBP 
is one of the proteins which is attacked by the immune system [12, 13], so this protein plays 
an important role in demyelinating diseases such as Multiple sclerosis (MS) [14]. 
Immunological studies suggest that a key sequence recognised by the immune system (or 
epitope) is that found in positions 83 to 99 with primary structure Glu-Asn-Pro-Val-Val-His-
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Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro, which is therefore widely used in studies of multiple 
sclerosis (MS) disease [15].  
 
 
3.2 Methods: 
The X-ray crystallographic coordinates contained in PDB entry 1YMM, corresponding to the 
study of Hahn et al [15], were obtained from the Protein Data Bank [16]. These were loaded 
into the Molecular Operating Environment (MOE) software, and protonated according to 
typical protonation states. All hydrogen positions were optimised using the AMBER94 
forcefield, with heavy atoms fixed at their X-ray positions. Particular attention was paid to 
histidine residues, for which all possible protonation states were checked with both 
OPLSAA and AMBER94. This analysis revealed a clear preference for neutral histidines in 
all cases, in agreement with Wucherpfenning who stated that LYS93 is the only charged 
residue on this peptide [17]. Truncation of the PDB coordinates to individual amino-acids 
resulted in neutral species, to avoid charge-charge terms dominating binding energies. 
 
Ab initio calculations were performed using the MOLPRO package of programs [18]. DF-
LMP2 calculations and SCSN scaling employed the aug-cc-pVTZ orbital and fitting basis 
sets [19-21]. The Gaussian03 suite of programmes was used to calculate the interaction 
energies for AM1, PM3, BHandH and MP2/6-31G(0.25d) [22]. The MOPAC programme was 
used to carry out PM6, RM1 and RM1BH calculations. For larger systems with the RM1 
method, we used the MOZYME keyword to accelerate the calculations [23]. MOE was used 
for OPLS-AA and AMBER94 calculations.  For PM3-D and AM1-D methods, we used 
optimised parameters for H, C, N, and O reported by McNamara et al [9]. Dispersion 
corrections were calculated following the procedure set out by Grimme [24]. 
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Before we used these modified methods, we tested them by calculating the interaction 
energies for S22 complexes. The results were exactly the same as the results on the 
McNamara study. After this, we calculate the dispersion term to S22 complexes and add it 
to the AM1 and PM3 results. The results were the same as the results in the study Table 
(3.1). After, we were sure about our scripts, we started to use these new methods to 
calculate the interaction energies for our peptides.  
 
Table 3.1: PM3-D and AM1-D interaction energies for S22 complexes. 
 
  
               
PM3-D   
               
AM1-D   
complex name This work McNamara results This work McNamara results 
 water_dimer -5.14 -5.14 -7.29 -7.29 
phenol_dimer -7.52 -7.52 -9.76 -9.76 
methane_dimer -1.24 -1.24 -0.94 -0.94 
 ammonia_dimer -1.77 -1.77 -3.43 -3.43 
 benzene_water cs -3.65 -3.65 -3.43 -3.43 
pyrazine_dimer -4.20 -4.2 -4.57 -4.57 
benzene_hcn_cs -4.43 -4.43 -4.44 -4.44 
uracil_dimer_stack -6.78 -6.78 -10.56 -10.56 
uracil_dimer_hb -20.30 -20.3 -20.15 -20.15 
adenine_thymine -17.33 -17.33 -16.58 -16.58 
adenine_thymine_stack -10.63 -10.63 -12.20 -12.2 
ethene_dimer d2d -3.60 -3.6 -3.31 -3.31 
formic_acid_dimer c2h -18.57 -18.57 -15.45 -15.45 
formamide_dimer -15.37 -15.37 -17.16 -17.16 
benzene_ammonia -2.96 -2.96 -3.00 -3 
benzene_methane -2.42 -2.42 -2.12 -2.12 
benzene_dimer c2v -4.15 -4.15 -3.85 -3.85 
benzene_dimer c2h -4.30 -4.3 -2.90 -2.9 
indole_benzene_t-shape_c1 -6.65 -6.65 -7.10 -7.1 
indole_benzene_stack_c1 -6.09 -6.09 -4.04 -4.04 
2-pyridoxine_2-
aminopyridine -17.52 -17.52 -16.50 -16.5 
ethene_ethine c2v -1.85 -1.85 -1.61 -1.61 
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3.3 Results and Discussion: 
3.3.1 Pairwise calculations: 
MOE was used to obtain each individual pairwise interaction between amino acids in the 
complex, based on distance criteria between peptide and any atom of receptor residue, as 
defined in the “ligand interactions” procedure used in MOE [25]. A total of 49 interactions 
were identified by these criteria, and are listed in Table (3.2) and Table (3.3). 
 
Table 3.2: Peptide-protein interactions identified by distance criteria. 
 
Peptide residues α  residues β residues 
Glu85 - - 
Asn86 Ser53, Arg50, Phe51 - 
Pro87 Ser53, Ala52, Phe51 - 
Val88 Ser53 His81 
Val89 Ser53, Phe54 Asn82 
His90 Phe24 Tyr78, His81, Asn82 
Phe91 Gln9, Phe22, Phe54, Gly58, Asn62 Tyr78 
Phe92 Gln9, Asn62 Arg13, Phe26, Asp28, Gln70, Ala71, Tyr78 
Lys93 Asn62 - 
Asn94 Glu11, Asn62, Val65, Asp66 Arg13 
Ile95 Val65, Asn69 Trp61, Ile67 
Val96 Asn69 Trp61 
Thr97 Asn69, Ile72 Asp57, Trp61 
Pro98 Arg76 Pro56, Asp57, Tyr60 
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Table 3.3: 49 pairwise interaction energies (kcal/mole) 
Peptide 
residues 
α  
residues 
β 
residues OPLSAA MP2 PM3 AM1 PM3-D AM1-D RM1BH PM6 RM1 RM1-D RM1-D(0.5) BhandH PM6-D 
ASN86 SER53  7.99 13.32 17.81 22.32 15.43 19.95 8.28 11.16 10.35 7.59 9.24 5.24 8.79 
ASN86 ARG50  1.65 6.426 5.62 8.626 3.73 6.73 2.64 4.12 6.30 3.42 5.15 1.98 2.23 
ASN86 PHE51  -1.41 -1.314 0.61 -0.17 -2.93 -3.71 1.43 0.35 1.44 -2.50 -0.13 -0.77 -3.19 
PRO87 SER53  -2.33 -0.635 0.97 -0.05 -1.41 -2.43 -2.01 -4.05 0.22 -2.52 -0.87 -8.35 -6.43 
PRO87 PHE51  -1.18 -0.661 0.60 0.007 -0.96 -1.55 0.17 -0.56 0.17 -1.63 -0.54 -1.79 -2.12 
PRO87 Ala 52  -2.9 -2.372 -0.52 -1.42 -2.80 -3.70 -0.53 -3.02 -0.5 -3.14 -1.55 -4.21 -5.30 
VAL88  HIS81 -3.06 -4.993 -3.08 -0.11 -4.77 -1.79 -5.01 -4.07 -1.16 -3.22 -1.98 -8.06 -5.75 
VAL88 Ser53  -1.69 0.221 2.13 -0.47 -3.46 -6.05 6.84 -3.29 2.71 -4.22 -0.06 -5.34 -8.88 
VAL89 Ser53  -2.99 -1.456 0.43 0.45 -1.20 -1.18 0.49 0.24 0.49 -1.50 -0.30 -0.15 -1.39 
VAL89 Phe54  -1.67 -1.199 -0.30 -0.6 -3.72 -4.02 0.60 -1.53 0.78 -3.02 -0.73 -3.33 -4.95 
VAL89  Asn82 -3.87 -1.901 -0.17 -1 -3.44 -4.27 -0.63 -2.77 -0.62 -4.47 -2.16 -4.44 -6.03 
His90 phe24  -1.37 -1.019 -0.22 -0.47 -1.07 -1.33 -0.34 -0.77 -0.33 -1.29 -0.71 -1.78 -1.63 
His90  tyr78 -2.12 -1.217 0.29 0.63 -2.43 -2.09 0.67 0.28 0.68 -2.25 -0.49 -1.29 -2.43 
His90  HIS81 -2.6 -4.063 -1.39 -0.92 -6.18 -5.70 1.21 0.00 1.21 -4.04 -0.88 -1.64 -4.78 
His90  Asn82 -3.59 -1.288 1.83 -1.81 -0.74 -4.39 0.13 -1.49 0.15 -3.19 -1.18 -3.49 -4.07 
Phe91 Gln9  -4.79 -3.333 -1.04 -1.55 -4.42 -4.92 -1.32 -3.31 -1.32 -5.10 -2.83 -5.55 -6.68 
Phe91 Phe22  -0.8 -0.274 -0.57 0.165 -2.96 -2.22 0.49 0.19 0.49 -2.27 -0.61 -0.42 -2.20 
Phe91 Phe54  3.44 0.281 -2.10 0.926 -4.93 -1.90 -0.08 -0.59 -0.08 -3.43 -1.42 -0.34 -3.42 
Phe91 Gly58  -0.13 0.252 1.02 1.72 -2.89 -2.19 1.65 0.20 1.66 -3.02 -0.21 -0.72 -3.70 
Phe91 Asn62  -2.17 -2.194 -0.13 0.092 -2.48 -2.26 -0.58 -1.13 -0.58 -3.07 -1.57 -2.32 -3.49 
Phe91  tyr78 -1.15 -1.256 -1.03 -0.22 -3.62 -2.81 0.20 -0.74 0.20 -2.89 -1.03 -1.42 -3.33 
PHE92 GLN9  -7.23 -5.017 -1.49 0.138 -5.02 -3.39 -6.63 -7.32 -0.88 -5.21 -2.60 -12.32 -10.85 
PHE92  Arg13 -4.15 -5.935 -3.71 -2.65 -10.8 -9.79 -2.77 -5.28 -2.78 -11.20 -6.15 -8.36 -12.42 
PHE92  Phe26 -3.13 -2.685 0.14 1.054 -4.30 -3.39 0.29 -0.60 0.29 -4.64 -1.68 -2.64 -5.05 
PHE92  Asp28 -0.084 -3.863 -1.72 -2.8 -3.31 -4.39 -2.67 -4.47 -1.93 -3.95 -2.73 -7.52 -6.05 
PHE92 Asn62  -2.01 -1.627 -0.36 -0.81 -1.35 -1.81 -0.58 -1.13 -0.58 -1.64 -1.00 -1.54 -2.13 
PHE92  Gln70 -1.83 -0.949 0.09 0.478 -1.72 -1.33 0.31 0.24 0.31 -1.55 -0.43 -0.04 -1.57 
PHE92  Ala71 -1.07 -0.573 -0.78 -0.01 -2.80 -2.02 0.25 -0.07 0.25 -2.00 -0.65 -0.86 -2.08 
PHE92  tyr78 -3.33 -1.278 0.40 0.694 -5.01 -4.72 0.94 -0.54 0.94 -5.40 -1.59 -1.97 -5.95 
Lys93 Asn62  -4.79 -6.123 -4.95 -5.09 -6.48 -6.62 -5.34 -6.88 -5.34 -6.95 -5.98 -8.12 -8.40 
ASN94 GLU11  -9.33 -14.94 -10.61 -10.9 -12.28 -12.61 -9.70 -12.9 -8.86 -10.50 -9.52 -17.82 -14.58 
ASN94 ASN62  22.09 19.76 20.56 26.92 13.03 19.38 4.79 3.80 12.47 11.42 12.04 4.59 -3.729 
ASN94  ARG13 -11.86 -11.54 -2.99 1.423 -6.76 -2.35 -10.21 -10.4 -6.83 -11.90 -8.87 -15.34 -14.18 
ASN94 Val65  -1.96 -1.12 -0.72 0.15 -4.27 -3.38 0.52 -0.11 0.53 -3.25 -0.98 -1.64 -3.64 
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ASN94 Asp66  -4.55 -7.86 -6.38 -5.58 -7.93 -7.12 -5.06 -6.94 -5.06 -6.62 -5.68 -8.65 -8.48 
Ile95  trp61 -2.84 -2.17 -0.26 0.18 -3.57 -3.13 0.20 -0.41 0.20 -3.33 -1.20 -1.68 -3.71 
Ile95 Val65  -1.07 -0.27 0.28 0.52 -1.05 -0.81 0.30 0.26 0.31 -1.11 -0.25 -0.09 -1.07 
Ile95  ile67 5.8 3.72 0.51 2.48 -5.78 -3.81 4.86 2.45 4.86 -3.52 1.51 1.49 -3.84 
Ile95 asn69  -2.45 -2.99 -0.98 -1.94 -1.99 -2.94 -0.99 -1.95 -1.00 -2.24 -1.49 -2.68 -2.95 
VAL96  TRP61 -3.87 -5.25 -1.58 -3.15 -3.19 -4.76 -2.38 -3.91 -0.81 -2.73 -1.57 -7.17 -5.51 
VAL96 asn69  -3.53 -1.44 -0.92 -1.33 -2.88 -3.29 -1.24 -2.95 -1.24 -3.49 -2.14 -3.92 -4.91 
THR97 ASN69  -4.78 -3.17 0.13 -1.32 -3.71 -5.16 -0.02 -2.52 0.04 -4.31 -1.69 -4.57 -6.36 
thr97  asp57 18.58 5.59 3.07 0.81 0.83 -1.41 -2.24 -3.49 0.12 -2.91 -1.08 -2.19 -5.72 
thr97  TRP61 -1.46 -0.64 -0.01 0.74 -3.02 -2.27 0.37 0.06 0.37 -2.78 -0.88 -1.18 -2.95 
thr97 ile72  -0.72 0.43 -0.96 0.35 -5.20 -3.88 0.76 -0.19 0.76 -4.26 -1.24 -0.81 -4.42 
Pro98  Pro56 5.44 2.07 1.58 0.87 -1.58 -2.29 2.61 0.44 2.99 -0.79 1.47 -0.09 -2.73 
Pro98  asp57 11.25 -2.91 -3.43 -2.60 -8.75 -7.91 -3.59 -5.88 -0.27 -7.09 -2.99 -9.57 -11.19 
Pro98  Tyr60 4.16 2.40 0.78 2.33 -4.50 -2.95 4.31 2.18 4.30 -2.47 1.59 1.56 -3.10 
Pro98 Arg76  1.45 0.40 1.12 1.51 -1.19 -0.80 1.73 2.38 1.72 -0.69 0.76 0.71 0.06 
MUE a   2.08  1.97 2.15 2.33 2.33 2.27 1.68 2.17 2.13 1.36 2.39 3.48 
MSE a   -0.46  -1.31 -1.74 1.74 1.31 -0.81 0.41 -1.51 1.92 -0.13 2.12 3.46 
MAX a   5.3  3.21 4.77 9.51 7.54 14.96 15.95 7.29 8.49 7.71 15.17 23.49 
MIN a   -14.16  -8.54 -13 -4.77 -9.18 -6.62 -4.07 -6.08 -4.4 -5.41 -2.42 -0.36 
a. relative to MP2 method.  
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Based on MP2 results, it has been found that the first residue of our peptide (Glu85) is not 
interacting with any receptor residues. It interacts with Asn86 residues in the peptide chain 
Figure (3.1). 
 
 
Figure 3.1: Glu85 structure on the peptide chain 
 
The second residue (Asn86) has three destabilization interactions. So, we can see that 
Asn86 does not interact with the receptor. Pro87 is a stable residue compared with Glu85 
and Asn86.  Val88 has good interactions with the receptor. Val 89, which is hydrophobic 
residue [17], has three interactions. The most stable interaction according to our 
calculations is Val89- Asn82. His90 has four interactions. The more interesting interaction is 
with His81,which is believed to be a stacking interaction between the two aromatic groups 
Figure 3.2. His90 is one of the most significant residues for our peptide- receptor 
interactions [15, 17, 26].   
 
 
 
 
 
 
 
Figure 3.2: His90- His81 stacking interaction. 
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Phe91 has six interactions. Most of these interactions are stabilizing interactions. The most 
stable interaction for Phe91 is with Gln9 from the α chain. Phe92, which is hydrophobic 
residue [17],  is the most stabilization residue in the peptide bound to the MHC class II 
receptor according to MP2 interaction energies, and one of the most significant residues for 
the peptide- receptor interactions Figure (3.3) [26]. It has eight stabilizing interactions with 
the receptor residues. According to MOE programme Phe92 has hydrogen bond interaction 
with Gln9.  Phe92 is placed between two aromatic molecules Phe26 and Tyr78. These two 
residues with Gln70, Ala71, Asp28 and Arg13 create a hydrophobic pocket [17]. Ala71 
makes a space which is occupied with Phe92 aromatic group which stabilises the 
interaction of this residue.   
 
 
 
 
 
 
Figure 3.3: A) Phe92 (pink colour) inside the pocket of the MHC residues. 
B) Phe92 (blue colour), Gln9 (red colour) and Gln70, Ala71, Asp28, Phe26, Tyr78 and 
Arg13 (green colour) create a hydrophobic pocket. 
 
Lys93 is the only charged amino acid on this peptide [17]. Lys93 has just one interaction. 
This interaction is considered one of the significant interactions with the receptor [17, 26]. 
The position of Lys93 on the receptor prefer positive charge residue [27]. Asn94, which is a 
polar residue, interacts with five residues. Three of these interactions are Hydrogen-bond 
interactions. Asn94 is located inside pocket which created by five receptor residues Figure 
(3.4). From the calculations, Asn94 is the second most stabilizing residue, after Phe92, 
which bound to the receptor according to MP2 interaction energies. Ile95 has four 
A B 
 65 
 
interactions. Three of these interactions are stabilizing interactions. Val96 has two 
stabilizing interactions with the receptor. One of these interactions is a hydrogen-bond 
interaction according to MOE. Thr97 has four interactions. One of them is hydrogen-bond 
interaction. Pro98, which is the last residue of the peptide, it has three interactions. 
 
 
Figure3.4: A)Asn94 (pink colour) in side the pocket. B) Asn94 (blue colour), Asn62, Glu11, 
and Arg13 (red colour) H-bond interactions, and Val65 and Asp66 (green colour) dispersion 
interactions. 
 
A subset of nine interactions, Val88-Ser53α, Phe91-Phe54α, Ile95-Ile67β, Thr97-Asp57β, 
Pro98-Pro56 β, Pro98-Asp57β, Pro98-Tyr60 β, Asn86-Asn62α and Val88-His81β, were 
selected for study using DF-LMP2 and SCSN methods. Selections were made to cover a 
range of interaction energies and types. These data were used as a benchmark to test the 
performance of faster, more approximate methods. As shown in Table (3.4), MP2/6-
31G(0.25d) gives reliable results, with MUE of 0.92 kcal/mol when compared with SCSN. 
Similar performance (MUE = 0.84 kcal/mol) was found when using SCS(MI) as the 
benchmark method Table (3.5).  
 
 
 
 
 
 
 
B A 
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Table 3.4: the MUE (mean unsigned error), MSE (mean signed error), MAX and MIN error 
for several methods compared with SCSN aug-cc-pVTZ for nine pairwise amino acid 
interactions (kcal/mol). 
 
 
 
 
 
 
 
 
 
 
a) Errors defined as ESCSN – EMethod, and hence are positive for overbinding relative to SCSN, 
negative for underbinding. 
 
Table (3.4) also contains data for several more approximate methods. All are considerably 
worse than MP2/6-31G(0.25d) for these data, although some semi-empirical methods such 
as PM6, PM3 and RM1 show some promise. Slightly surprisingly, inclusion of dispersion 
correction (using the default parameters from ref. [23]) actually makes predictions worse in 
all cases: this aspect will be discussed in more detail below. For these data at least, OLPS-
AA does not appear to be a suitable method to predict interaction energy. On the basis of 
these results, MP2/6-31G(0.25d) was selected as the most appropriate method to use as a 
benchmark for all pairwise interactions and for larger systems. 
MUE MSE MAX a MIN a
PM6-D 7.02 -7.02 -3.22 -13.09
OPLS-AA 6 -4.73 5.32 -17.07
PM3-D 4.22 -3.49 2.13 -8.82
AM1-D 4.17 -1.78 6.64 -6.44
AM1 4.07 1.47 15.96 -4.87
RM1-BH 3.32 -0.12 8.51 -8.1
BHandH 3.19 3.19 8.07 0.41
RM1-D 3.16 -2.48 3.05 -5.59
RM1 2.82 1.38 4.74 -3.36
PM3 2.11 -0.21 2.52 -4.6
PM6 1.81 -1.39 1.83 -6.97
MP2/6-31G(0.25d) 0.92 -0.92 -0.01 -2.11
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Table 3.5: the MUE (mean unsigned error), MSE (mean signed error), MAX and MIN error 
for several methods compared with SCS(MI) aug-cc-pVTZ for nine pairwise amino acid 
interactions (kcal/mol). 
 MUE MSE MAX MIN 
PM6-D 6.66 -6.66 -3.08 -12.62 
OPLS-AA 5.99 -4.38 6.52 -16.87 
PM3-D 4.19 3.84 8.91 -0.93 
AM1-D 4.14 2.13 6.65 -5.44 
BHandH 3.55 3.55 9.27 0.51 
AM1 3.45 -2.27 4.14 -12.17 
RM1-D 3.4 2.84 6.52 -2.53 
RM1-BH 3.3 0.23 9.71 -7.77 
RM1 2.8 -1.03 4.16 -4.22 
PM6 2.03 1.74 7.18 -1.31 
PM3  2.01 0.14 8.91 -0.93 
MP2/6-31G(0.25d) 0.84 -0.57 1.19 -1.9 
 
 
Following this test, all 49 pairwise interactions between amino acids were calculated using 
several methods: results are summarised in Table (3.6), using MP2/6-31G(0.25d) as a 
benchmark, with full details reported in Table (3.3). This data shows that the OPLS-AA force 
field method gave good agreement with MP2 for several interactions, but failed for several 
others such as PRO98-ASP57, for which the interaction energy is -2.91 kcal/mol with 
MP2/6-31G(0.25d) and +11.25 kcal/mol according to OPLS-AA. The overall MUE error 
compared with MP2/6-31G(0.25d) is 2.08 kcal/mol, which although rather smaller than that 
reported in Table (3.4) (for fewer interactions) is rather greater than the 1 kcal/mol generally 
accepted as “chemical accuracy”.  
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Table 3.6: MUE, MSE, MAX, and MIN relative to MP2/6-31G(0.25d) for all 49 amino acid 
interactions identified by MOE (kcal/mol). 
 MUE MSE MAX MIN 
OPLS-AA a 2.08 -0.46 
 
5.3 -14.16 
PM3 1.97 -1.31 3.21 -8.54 
AM1 2.15 -1.74 4.77 -12.96 
PM3-D 2.33 1.74 9.51 -4.77 
AM1-D 2.33 1.31 7.54 -9.18 
RM1BH 2.27 -0.81 14.96 -6.62 
PM6 1.68 0.41 15.95 -4.07 
RM1 2.17 -1.51 7.29 -6.08 
RM1-D 2.13 1.92 8.49 -4.4 
RM1-D(0.7) 1.36 -0.14 7.71 -5.41 
BHandH 2.39 2.12 15.17 -2.42 
PM6-D 3.48 3.46 23.49 -0.36 
a) Cut-off for electrostatic interaction energy of 10 Å employed. Without this cut-off, 
interaction energies differ by up to 0.17 kcal/mol, MUE identical at the precision shown. 
 
 
BHandH results in overestimated interaction energies, for instance �E for PHE92-GLN9 is    
-12.3 kcal/mol using BHandH and just -5.01 kcal/mol with MP2/ 6-31G(0.25d). The overall 
MUE comparing with MP2/6-31G(0.25) calculations is 2.39 kcal/mol, again rather larger 
than required for our purposes. Semi-empirical methods PM3 and AM1 give similar overall 
errors, with MUE of 1.97 kcal/mol for PM3 and 2.15 kcal/mol for AM1, and more often than 
not underestimate interaction energies. Similar performance is found for re-
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parameterisations RM1 and RM1-BH, whereas PM6 shows a slight improvement over other 
related methods. 
 
Including a dispersion correction, and modifying parameters according to McNamara [9], 
does not improve performance, with MUE of 2.33 kcal/mol for both AM1-D and PM3-D. To 
analyse these data in more detail, errors for hydrogen bonded, dispersion bound, and 
charged interactions were calculated separately, and found to be 1.92, 2.41 and 2.82 
kcal/mol for PM3-D, and 2.36, 2.23, and 3.07 kcal/mol for AM1-D, respectively. Notably, 
Table (3.6) shows that the mean signed error (MSE) changes sign on addition of dispersion, 
suggesting that the default dispersion correction overcompensates for the shortcomings of 
the underlying methods in these cases. The form of the dispersion correction given by 
Grimme [24] is shown in equation (3.1): 
���� n
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where s6 is a global scaling factor that must be optimised for the method to be corrected. 
Tables (3.4) and (3.6) employed the default scaling factor of 1.4, as in the initial reports of 
AM1-D and PM3-D method. Varying the s6 parameter, the optimal combination of method 
and global scaling was located to be RM1 with s6 = 0.7, for which an overall MUE of 1.36 
kcal/mol was obtained. The response of this overall error to the value of s6 is shown in 
Figure (3.5). Repeating this procedure with other semi-empirical methods gave similar 
curves but slightly higher MUE values, with the exception of PM6 for which the optimal 
value of s6 was zero, i.e. any attempt to improve on predictions by adding a dispersion term 
actually gave worse performance. 
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Figure 3.5 Response of RM1-D error as a function of global scaling parameter s6. 
 
Previous studies [17, 26, 27] indicate that the most important residues for interaction of this 
MBP epitope with MHC-II are the central residues Val88 to Asn94. In general, our 
calculations are in agreement with these findings, indicating that most stabilisation of the 
complex stems from these residues’ interactions. Table (3.7) reports the sum of individual 
pairwise interaction energies from both MP2/6-31G(0.25d) and RM1-D with s6 = 0.7. Both 
methods show that Phe92 and Asn94 are particularly strongly stabilising, with significant 
further contributions from all except the terminal residues. Table (3.7) also reports 
interaction energies of each peptide residue with all receptor residues identified as 
interacting, calculated with RM1-D. This data shows very similar trends to those from 
pairwise data, with Phe92 and Asn94 considerably more stabilising than other residues, and 
terminal Asn86 and Pro98 destabilising the complex. The difference between pairwise and 
direct interaction energies is the many-body term: no clear trend is apparent in this data, but 
the size of this term in some cases, e.g. more than 4 kcal/mol for Phe92, suggests that 
conclusions from pairwise calculations should be treated with caution. Summing either 
pairwise or direct interaction energies gives estimates of the overall stabilisation of the 
complex of -59.0 and -57.3 kcal/mol, respectively. 
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Table 3.7: Stabilisation energies due to each residue in peptide (kcal/mol) 
 Sum of pairwise Direct Many body a 
 MP2 RM1-D RM1-D  
Glu85 - - - - 
Asn86 +18.44 +11.51 +14.20 +2.69 
Pro87 -3.67 -3.30 -3.21 +0.09 
Val88 -4.77 -4.05 -2.09 +1.96 
Val89 -4.56 -3.41 -3.52 -0.11 
His90 -7.59 -4.77 -3.76 +1.01 
Phe91 -6.52 -8.05 -8.36 -0.31 
Phe92 -21.93 -13.62 -17.85 -4.23 
Lys93 -6.12 -5.86 -5.86 0.00 
Asn94 -15.71 -21.08 -16.77 +4.33 
Ile95 -1.73 -2.86 -1.60 +1.26 
Val96 -6.70 -3.93 -3.84 +0.09 
Thr97 +2.22 -2.87 -5.36 -2.49 
Pro98 +1.97 +3.28 +0.70 -2.58 
a. the difference between sum of pairwise and direct results from RM1-D method.  
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3.3.2 Dipeptides and heptapeptides calculations: 
The speed of semi-empirical methods such as RM1 allows us to examine the interaction 
energies of larger models of the peptide than single amino acids. The peptide was cut into 
seven dipeptides, as well as two heptapeptides, and the interaction energy with all receptor 
residues identified in Table (3.3) calculated, as shown in Table (3.8). This data further 
indicates that stabilisation comes mainly from the central residues, with the dipeptide Lys93-
Asn94 particularly strongly bound. Table (3.8) also shows that much greater binding results 
from the heptapeptide Phe92-Pro98 than from Glu85-Phe91, perhaps unsurprisingly given 
that this contains both of the most strongly bound single residues. 
 
Table 3.8: Interaction energies of larger models (kcal/mol) by RM1-D 
Dipeptides  
Glu85-Asn86 10.62 
Pro87-Val88 -6.34 
Val89-His90 -7.45 
Phe91-Phe92 -17.88 
Lys93-Asn94 -58.84 
Ile95-Val96 -7.63 
Thr97-Pro98 1.72 
Sum -85.79 
  
Heptapeptides  
  
Glu85-Phe91 -20.16 
Phe92-Pro98 -81.83 
Sum -101.99 
 
 
These data also show that the estimated overall stabilisation of the complex increases as 
the size of the model peptides increase. Considering only single amino acids, RM1-D 
estimate is –57.3 kcal/mol, rising to –85.8 kcal/mol from dipeptides and to –102.0 kcal/mol 
from heptapeptides. Calculating all 14 residues as one molecule with all 29 receptor 
residues gives an interaction energy of -110.0 kcal/mol, i.e. larger still. From these data it 
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seems clear that cutting the peptide into individual amino acids causes significant error in 
prediction of overall binding energy.  
 
 
3.3.3 Peptide (MBP)-receptor (MHC II) calculations: 
The size of the receptor was then increased by progressively adding more amino acids, 
using a 4.5Å distance cutoff repeatedly until all receptor residues were included. Table (3.9) 
shows that there is a large effect of the size of the model on the calculated interaction 
between peptide and receptor, with the interaction energy of the peptide with the entire 
receptor calculated at -263.1 kcal/mol. Figure (3.6) shows how interaction energy varies 
with model size, demonstrating that even with almost 300 receptor residues, or 80% of the 
entire protein, convergence is not reached. It is notable that the total charge on the peptide-
protein complex changes from neutrality to -13 as the size of the receptor model increases, 
suggesting that long-range electrostatic forces may be playing a significant role here. 
 
 
Table 3.9: Interaction energy of peptide with progressively larger models of receptor 
(kcal/mol) 
No. amino acids 
in receptor model 
Total charge  
(e) 
�E 
 
29 0 -110.02 
47 -1 -141.87 
135 -6 -211.13 
198 -9 -218.63 
291 -9 -236.87 
325 -12 -256.49 
360 (all) -13 -263.10 
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Figure 3.6: The interaction energies for large systems (kcal/mol). 
 
 
3.3.4 Molecular Dynamics snapshots calculations: 
It is well known that both peptide and receptor are flexible systems, such that calculations 
on the single static X-ray structure may not represent the true nature of this interaction. We 
have therefore calculated interaction energies for ten low-energy snapshots from molecular 
dynamics (average RMSD Cα =1.09 Å), taken from reference [28], in order to study the 
effect of the motion in our peptide-receptor interaction energy (Table (3.10) and Figure 
(3.7)). Interaction energies were calculated using OPLS-AA and RM1-D using the entire 
receptor. This data shows that there is a large effect of the motion in our peptide-receptor 
interaction energy, despite the relatively small RMSD across the snapshots. Detailed 
analysis of ligand-receptor interactions of each snapshot does not reveal any clear origin for 
these trends. For instance, snapshot 8 is less strongly bound while snapshot 6 is more 
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strongly bound than average, but snapshot 6 actually has fewer ‘native’ interactions than 
snapshot 8 Table (3.11). Thus, it seems that the origin of the variation in binding energy is 
not simple, and cannot be assigned to any single interaction. Slightly surprisingly, in the 
light of the above results, OPLS-AA shows very similar behaviour to RM1-D results, with a 
difference in means of 6.9 kcal/mol, and very similar trends in interaction energy across 
snapshots. More work was done to determine whether longer dynamical simulations are 
required to properly model peptide-protein binding, and results are reported in chapter 5. 
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Table 3.10: Interaction energies for ten molecular dynamics snapshots (kcal/mol) 
Snapshot  OPLSAA RM1-D (0.7) 
1 -175.19 -159.97 
2 -192.53 -193.30 
3 -177.48 -167.09 
4 -157.17 -195.14 
5 -193.89 -208.91 
6 -194.36 -211.52 
7 -178.60 -174.42 
8 -121.08 -137.40 
9 -175.37 -186.87 
10 -150.88 -150.81 
   
Mean -171.66 -178.54 
Standard deviation 22.98 24.78 
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Figure 3.7: Interaction energies for ten molecular dynamics snapshots (kcal/mol). 
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Table 3.11 Changes in ligand Interactions 
for 10 MD snapshots  
    
      
 1  2 
 new missing  new missing 
Glu85 - -  - - 
Asn86  Arg (a)  Gly(a), Ala(a)  
Pro87    Val(b)  
Val88    Val(b)  
Val89    Val(b) Asn(b) 
His90 Thr (b) Phe, no stacking with His  Thr(b) His(b) 
Phe91 Ala (b) Gly (a)  Ala(a), Glu(a) Tyr(b), Phe22(a) 
Phe92    Ala(b), Gln(b) Asp(b) 
Lys93 Gln (a) Asn (a)  Gln(b)  
Asn94  no H-bond with Asn (a)  No H-bond with Asn  
Ile95 Tyr (b) Ile (b)  Tyr(b), Asp(a), Arg(b) Ile(b) 
Val96 Val (a)   Val(a)  
Thr97 Arg(a), Met(a), Ile(a) Trp (b)  Met(a), Arg(a) Ile(a) 
Pro98 Ile(a) Pro(b), Asp(b), Tyr(b)  Ile(a) Pro(b), Asp(b), Tyr(b) 
      
      
 3  4 
 new missing  new missing 
Glu85 - -  - - 
Asn86 Gly(a), Ala(a) Arg, Phe  Gly(a), Ala(a)  
Pro87 Val(b)   Val(b)  
Val88 Val(b)     
Val89 Phe31(a), Phe23(a)   Ple(a), Vla(b)  
His90 Asn(a)2H-bonds, Tyr(a), Thr(a) Phe(a), His(b), Asn(b), Tyr(b)  Thr(b) Phe(a), No stcaking with His 
Phe91 Ala(a), Glu(a) Phe22(a)   Phe(a) 
Phe92 Ala(b) Gln(b)  Glu(a)  
Lys93 Ile(b), Gln(b) Asn(a)  Gln(b)  
Asn94      
Ile95 Tyr(b) Ile(b)  Tyr(b)  
Val96 Val(a)   Val(a)  
Thr97 Arg(a) 2H-bonds, Met(a) Trp(b)   Ile(a) 
Pro98  Arg(a), Pro(b)   Asp(b),Pro(b),Arg(a) 
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 5  6 
 new missing  new missing 
Glu85 - -  - - 
Asn86 Arg(a)   Ala(a), Gly(a)H-bond  
Pro87 Val(b)    Ala(a) 
Val88 His(b) Phe(a), Ala(a)  Phe(a)  
Val89 Val(b)   Phe(a),His(b), Val(b)  
His90 Thr(b) Phe(a), No stacking with His    
Phe91 Ala(a) Asn(a)  Ala(a), Glua) Phe(a), Tyr(b) 
Phe92 Ala(b)    Ala(b), Gln(b) 
Lys93 Gln(b)   Gln(b) Asn(a) 
Asn94  No H-bond wih Asn    
Ile95  Val(a), Trp(b)  Tyr(b) Val(a) 
Val96 Val(a)   Val(a)  
Thr97 Arg(a)   Met(a), Arg(a) Trp(b) 
Pro98  Pro(b), Asp(b)  Trp(b) Pro(b) 
      
 7  8 
 new missing  new missing 
Glu85 - -  - - 
Asn86 Ala(a), Gly(a)H-bond   Ala(a), Gly(a)  
Pro87  Ala(a)  Val(b)  
Val88 Phe(a)   Val(b)  
Val89 Phe(a),His(b), Val(b)   Val(b)  
His90    Thr(b)  
Phe91 Ala(a), Glua) Phe(a), Tyr(b)  Ala(a), Glu(a)  
Phe92  Ala(b), Gln(b)  Ala(b) Gln(a), Asp(b) 
Lys93 Gln(b) Asn(a)  ile(b), Phe(b)  
Asn94      
Ile95 Tyr(b) Val(a)  Asp(a), Tyr(b) ile(b) 
Val96 Val(a)   Val(a) Trp(b) 
Thr97 Met(a), Arg(a) Trp(b)  Arg(a), Asp(a), Met(a) Trp(b) 
Pro98 Trp(b) Pro(b)  ile(a) Pro(b), Asp(b), Tyr(b) 
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 9  10 
 new missing  new missing 
Glu85 - -  - - 
Asn86 Val(b) Arg(a)    
Pro87 Val(b)   Val(b)  
Val88    Glu(a)  
Val89 Phe(a)   Val(b)  
His90 Thr(b) His(b)  Thr(b) Phe(a) 
Phe91  Tyr(b)    
Phe92  Gln(b)   Ala(b) 
Lys93    Gln(b)  
Asn94 Ile(a)   Ile(a)  
Ile95  Ile(b), Trp(b)   Trp(b) 
Val96 Val(a) Ile(a), Trp(b), Asp(b)  Val(a) Trp(b) 
Thr97  Arg(a), Met(a)   Ile(a) 
Pro98 Ile(a) Pro(b), Asp(b), Tyr(b)  Ile(b), Trp(b) Arg(a), Pro(b), Asp(b) 
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3.4 Conclusions: 
We have tested several approximate methods against correlated ab initio calculations for 
their ability to predict the energy of interaction between amino acids, focussing on the 
interaction of a peptide implicated in multiple sclerosis with its biological MHC receptor. We 
find that the semi-empirical RM1 approach with additional correction for dispersion effects 
gives the best reproduction of ab initio data, with a mean unsigned error of a little more than 
1 kcal/mol over almost 50 interactions after optimisation of the global scaling factor s6. 
Performance is similar for several other parameterisations of semi-empirical theory, with 
RM1 chosen for its slightly better results. The atomistic forcefield OPLS-AA also shows 
promise, with a mean error of slightly more than 2 kcal/mol. 
 
The computational efficiency of this approach, especially when coupled with the MOZYME 
method, means that study of larger systems than pairs of amino acids is feasible. Many 
body effects are significant in some cases, although estimates of complex stabilisation from 
pairwise interactions and from larger calculations are similar. Increasing the size of model 
systems used to represent the bound peptide from single amino acids to dipeptides and 
heptapeptides increases the predicted interaction energy, as does expanding the number of 
amino acids used to model the receptor. We also show that the interaction energy varies 
significantly over 10 snapshots taken from a previous molecular dynamics study of this 
complex, confirming that predictions from a single static structure are unlikely to be 
representative. 
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Chapter 4:   
Calculation of non-covalent interactions in solvent for diverse peptides: 
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4.1 Introduction: 
Major Histocompatibility Complex (MHC) molecules are an important class of receptor 
in the immune system of all vertebrates: in humans they are termed human leukocyte 
antigens (HLA). Their role is to bind peptides presented to cell surfaces, hence allowing 
recognition of self or non-self and stimulating appropriate immune response in the case 
of non-self.  
 
MHC receptors are generally separated into class I and class II. Both have a single 
peptide binding site, which in class I is made up of a single amino-acid chain, whereas 
in class II the active site is located at the junction between two chains [1, 2]. Incorrect 
recognition of self peptides as being non-self is implicated in a number of auto-immune 
diseases such as multiple sclerosis and rheumatoid arthritis. The exact mechanism of 
this is not known but the concept of “molecular mimicry”, in which certain self-peptide 
sequences are sufficiently similar to non-self sequences to induce immune attack on the 
body, has been proposed. Prediction of the key binding event between peptide and 
MHC is therefore desirable, both in understanding the origin of these debilitating 
diseases and in design of new therapies to treat them. In the previous chapter we 
examined the binding of a key epitope of myelin basic protein, which is known to bind 
tightly to MHC II. In this section, we will consider the binding of a more diverse range of 
peptides to this receptor, to test whether methods can distinguish binding from non-
binding peptides 
 
Peptide-receptor interactions always occur in biological solvent [3]: therefore; in order to 
estimate the interaction energies for these complexes in appropriate ways, solvent must 
be considered in calculations.  Calculating interaction energies for large biological 
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complexes in solvent by computational methods is a challenging task [3]. Many 
approaches have been tested to estimate the effect of the solvent in these interactions 
[3] as discussed above.  
 
 
The speed of semi-empirical and molecular mechanics methods allows examination of 
the interaction energies of larger models of the peptide than single amino acids, 
especially when coupled with the MOZYME method. Therefore, we sought biological 
data to compare against the computational methods, in order to choose the most 
suitable method for predicting peptide-receptor interactions. IC50 data, i.e. the 
concentration required to inhibit 50% of binding of natural peptide in competitive 
binding, are widely used in such cases [4]. Although it is possible to convert IC50 to 
inhibition constant (Ki), which is directly related to binding free energy, using the Cheng-
Prusoff equation [5], we were not able to perform this conversion for the peptide-MHC II 
complexes under study, due to lack of information about ligand and receptor 
concentrations in literature data. IC50 values are sensitive to conditions such as the 
temperature and solvent [6, 7], it is therefore preferable to choose sets of IC50 data 
measured in a consistent manner in the same laboratory. We have therefore 
concentrated on several sets of peptide-MHCII receptor complexes with IC50 values 
measured in the same conditions, and with related X-ray structures published, and used 
these as tests of possible methods for prediction of peptide-MHCII binding using a 
variety of statistical techniques. We employed many of the methods discussed above 
(molecular mechanics methods OPLS-AA, AMBER94, and MM/GB-VI and semi-
empirical RM1-D and PM6-DH2 with COSMO [8]) to examine in detail the interaction of 
three sets of peptides with Major Histocompatibility Complex (MHC) class II receptor, 
and to compare calculated binding energies to available IC50 data. 
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4.2 Data Sets and Computational Methods: 
The first set studied is derived from hen egg lysozyme (HEL), and is based on the 
complex of  12 amino acids (MKRHGLDNYRGY) with MHC class II (mouse I-Ag7) [4]. 
The X-ray structure of the peptide-receptor complex was taken from PDB entry 1F3J. 
IC50 data has been reported for analogues of the HEL peptide, in which one or more N-
terminal and/or C-terminal residues are truncated to reveal the key residues for binding. 
IC50 values of 1000nM or more are denoted non-binders, and IC50 less than 1000nM are 
binders [4]. This set therefore contains 5 binders and 5 non-binders.  
 
 
The second set studied is based on a complex of myelin basic protein (MBP)-derived 
peptide with HLA DRB1*1501 [4, 9]. It contains fourteen amino acids 
(ENPVVHFFKNIVTP) [4, 9], and the relevant X-ray structure was taken from PDB entry 
1BX2 Figure (4.1).  In this set, each amino acid is replaced in turn by Ala [9], and values 
of IC50 measured [9]. In this set, all the IC50 values show stable interactions according to 
the 1000 nM cutoff used above, and many interactions have the same value of IC50. 
However, two peptides have rather higher IC50 values, in which Val89 and Phe92 are 
replaced by Ala. Both amino acids are known to form strong interactions, in pocket 1 
and pocket 4 of the binding site, respectively [4, 9, 10] and by replacing these amino 
acids with Ala, the binding affinity of the peptides decreased [9].  
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Figure 4.1 Two views of an epitope of myelin basic protein bound to an HLA receptor. 
P1 and P4 are the main “anchor” residues, while P3 and P5 are contacts to T-cell 
receptors. 
 
A third was taken from Southwood et al’s study [11], and contains 22 peptides with 
much more diverse sequences than the first two sets interacting with HLA DRB1*0101. 
In this case, X-ray structures of complexes are not available. Instead, manual docking 
was performed by mutating amino acids to the relevant sequence in MOE, using the X-
ray structure of human class II MHC protein HLa-DR1 in complex with the tight binding 
peptide A2 (103-117) [12] (PDB code 1AQD) as a template. In order to guide this 
procedure, possible amino acids that could act as “anchors” within binding pockets were 
identified by means of sequence-based prediction methods SYFPEITHI and SVMHC, 
as well as the algorithm set out by Southwood et al [11].  
 
 
SYFPEITHI is a databank and prediction algorithm for peptide-MHC binding, and 
contains a large range of ligands and peptide motifs, used to predict the peptide binding 
with MHC receptor [13-15] based on published motifs of amino acids and anchor 
positions. It calculates a score to identify the amino acid as anchor, auxiliary anchor, 
preferred residues or if the amino acid has “a negative effect on the binding ability” [14].  
88 
 
SVMHC is a prediction server for MHC class I and II, used to test the ability of peptides 
to bind with different MHC alleles, and to find the best “binders in a protein sequence” 
[16].  According to Donnes and Elofsson, the performance of SVMHC and SYFPEITHI 
for six MHC types common between these methods are compared [16], with SVMHC 
giving 95% correct predictions and 91% for SYFPEITHI [17].  The final sequence-based 
prediction method used is the algorithm set out by Southwood et al, which is specific for 
the DRB1*0101 allele MHC class II [11]. Each residue has value based on its position 
on the receptor, encoded into an in-house awk program to evaluate the most likely 
binding sites of the peptide based on these values.   
 
 
The X-ray crystallographic coordinates were obtained from PDB entry 1BX2 for MBP 
peptide and 1F3J for HEL peptide [4, 18-20]. For the Southwood data set, three 
prediction methods (SYFPEITHI, SVMHC and Southwood) were used to identify the 
best peptide anchors that fit in the receptor pockets. For the web-based prediction 
methods SVMHC [17] and SYFPEITHI [15],  the single letter of the residues of a peptide 
have been typed into the website. Then the correct allele and the nonamer peptide 
length have been selected.  These methods give a score for all possible alignment of a 
peptide in the receptor. The more positive a value is the more preferable the binding 
sites.  An algorithm method which developed by Southwood et al [11] for the 
DRB1*0101 allele has also been used. This method was used by an awk script written 
by Dr Platts.  The single letter residue of a peptide under the study was saved in a plain 
text file. When the program was run, it gives a value for the most likely alignment of a 
peptide in the receptor. Again the most positive value is the most likely alignment of a 
peptide in the receptor. We choose the best alignment of peptide in the receptor as a 
consensus of these methods, and only this alignment was used in further study. Table 
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(4.1) shows the prediction scores for these three methods. This table also shows that 
there are seven peptides from 22 peptides (blue colour) where just two methods predict 
the same anchor residue where the third method predicts another residue as an anchor.  
We have chosen the alignment which is predicted by two methods or more.  
 
 
Table 4.1: The scores and the best alignment of peptides for 22 Southwood set 
according to SYFPEITHI, SVMHC and Southwood algorithm methods.  
Peptide No. Peptide's alignment SVMHC SYFPEITHI AWK 
1188.34 HNWVNHAVPLAM 0.87 29 35.32 
1188.16 KSKYKLATSVLAGL 2.2 26 270.41 
1136.47 HHYFVDLIGGAMLS 0.38 35 0 
1188.32 GLAYKFVVPGAATP 0.55 32 1.34 
1136.16 LTSQFFLPALPVFT -995.9 25 0 
  
SQFFLPALPVFTWL 1.6 16 57.58 
27.415 VKYLVIVFLIFFDL 0.75 26 0 
  
YLVIVFLIFFDL 1.5 26 0 
27.403 LVNLLIFHING 1.6 25 31.17 
  
NLLIFHINGKIIK 0.7 31 0 
1136.21 PQEWKPAITVKVLP 1.2 26 183.62 
1136.28 AIIFLFGPPTALRS 1.49 26 4.8 
1136.11 VVFPASFFIKL 0.4 24 7.29 
  
PASFFIKLPIILA 1.1 27 6.8 
1136.14 TCFLIPLTSQFFLP 0.5 30 8.85 
1188.13 AGLLGNVSTVLLG 0.23 23 4.92 
  
AGLLGNVSTVLLGG -0.05 28 7.57 
1136.24 SNVLATITTGVLDI -2.3 28 0.93 
1136.12 IKLPIILAFATCF 0.6 25 10.81 
  
KLPIILAFATCFLI 0.79 26 5.29 
27.392 SSVFNVVNSSIGLI 0.35 23 0.14 
  
VFNVVNSSIGLIM -0.62 25 0 
27.417 VKNVIGPFMKA 0.4 31 0 
1136.55 PLSYNYIPVNSN -0.1 17 3.7 
1136.71 GSTYAASSATSVD -0.31 27 29.77 
1136.38 SSIIFGAFPSL -998.7 25 0 
27.388 MRKLAILSVSS 0.8 28 285.9 
1136.59.01a RVYQEPQVSPP -996.3 22 0 
1136.46 WSTMYLTHHYFVDL -1.5 17 0 
 
 
Coordinates were loaded into MOE, and protonated according to typical protonation 
states. All hydrogen positions were optimised using the AMBER94 forcefield, with heavy 
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atoms fixed at their X-ray positions. MOE program was used to calculate interaction 
energies using OPLSAA and AMBER94 force fields with dielectric constant 1 (vacuum), 
4, 20 and 78.4 (water) [1, 9]. MOE was used to calculate interaction energies with the 
Born solvation model, and also binding free energies with the MM/GBVI method. For 
this method, the dielectric constant is estimated according to the atoms present in the 
receptor, and a constrained energy minimization performed for ligand atoms [19, 20].  
 
MOPAC was used to carry out semi-empirical calculations, using the RM1-D tested in 
our previous study (Chapter 3) [10] and also the recent PM6-DH2 method, incorporating 
corrections for both dispersion and hydrogen bonding [21, 22]. For larger systems we 
used the MOZYME keyword to accelerate the calculations[2]. COSMO was used to 
estimate the effect on a solvent [23], with the same values for dielectric constant noted 
above [11]and NSPA (number of geometrical segments per atom) [19]equal to 122.   
 
Several statistical tests were used to investigate the suitability of different theoretical 
methods for prediction of peptide-MHCII bonding, using published IC50 values as a test. 
Specifically, we employed the standard Pearson R2 value against the negative log of 
IC50 values, Spearman’s rank correlation coefficient [24], and area under relative 
operating characteristic (ROC) curves by using the ROCkit package [25, 26]. In each 
case, a value of 1.0 indicates the ideal of perfect prediction. 
 
4.3 Results and discussions: 
Table (4.2) reports IC50 and interaction energies from OPLS-AA, AMBER94, MM/GBVI 
and RM1-D for the series of peptides based on HEL. According to Tsai (2002), the 
value 4 of the dielectric constant is suitable to be used in protein interaction [27], and so 
was employed here. Sequential removal of one to three residues from the C-terminus of 
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the native peptide increases IC50, a trend that is reflected in interaction energies from all 
methods considered. In contrast, removal of the N-terminal methionine residue actually 
increases potency: three of the five methods reflect this in increased binding, and the 
remaining two methods show only very small change in interaction energy. The shortest 
sequence, KRHGLDNY, is the least potent peptide in this data set, and again all 
methods predict weak binding for this peptide. From the GB-VI results, we can see that 
the binding energy is approximately additive: for example, removal of M from the N-
terminus of the peptide reduces binding energy by 1 kcal/mol independently of the other 
residues present. Similarly, simultaneous removal of both M and Y from N- and C-
termini reduces binding by 10.5 kcal/mol, a value that is very close to the sum of 
individual values (1.0 and 9.4 kcal/mol, respectively).  
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Table 4.2: IC50 values (nM) and interaction energies (kcal/mol) for HEL along with R2, 
rank correlation, and ROC area for each method. 
Peptide  
IC50 MM/ 
GBVI 
RM1-D/ 
COSMO 
PM6-DH2/ 
COSMO 
OPLS-AA/ 
Born 
AMBER94/ 
Born 
MKRHGLDNYRGY 250 -98.55 -214.89 -347.72 -129.53 -130.69 
MKRHGLDNYRG 600 -89.11 -205.87 -344.21 -119.61 -120.62 
MKRHGLDNYR 1000 -85.05 -188.91 -312.20 -112.30 -111.85 
MKRHGLDNY 1250 -75.98 -145.17 -293.10 -99.28 -95.17 
KRHGLDNYRGY 200 -97.57 -209.74 -337.18 -138.25 -135.53 
KRHGLDNYRG 250 -88.03 -200.92 -334.00 -128.33 -125.49 
KRHGLDNYR 5000 -83.94 -183.75 -302.20 -121.03 -116.70 
KRHGLDNY 30000 -74.83 -140.01 -282.69 -108.02 -100.01 
RHGLDNYRGY 500 -93.37 -150.54 -303.55 -125.39 -120.58 
RHGLDNYRG 3000 -83.83 -141.75 -300.10 -115.47 -110.54 
       
R2   0.65 0.46 0.65 0.43 0.55 
Rank correlation   0.88 0.82 0.63 0.80 0.86 
*(IC50-average) rank 
correlation   0.92 0.90 0.78 0.73 0.82 
ROC area  
(cutoff 1000 nM)   1.00 0.93 0.96 0.96 1.00 
* Rank correlation for the set after taking the average values for peptides in bold (IC50 = 250).  
 
Statistical measures across the entire data set clarify the differences in methods. 
Plotting log(1/IC50) against interaction energy gives some correlation for all methods, but 
noticeably superior performance for MM/GBVI over others considered Figure (4.2). The 
pattern is similar, but not as clear cut, when considering rank correlation, whether using 
raw or averaged data. ROC data shows that MM/GBVI and AMBER94/Born are able to 
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unambiguously separate binders from non-binders with no false positive or negatives, 
whereas PM6-DH2/COSMO, RM1-D/COSMO and OPLS-AA/Born cannot. However, 
even those methods give high values, indicating that their predictive ability remains 
rather good Figure (4.3) (4.4) (4.5) (4.6). 
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Figure 4.2 a) Linear and b) rank correlations from MM/GB-VI data for HEL data set. 
ROC curve not shown due to perfect prediction.  
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Figure 4.3 a) Linear, b) ROC curve and c) rank correlations from RM1-D data for HEL 
data set. 
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Figure 4.4 a) Linear, b) ROC curve and c) rank correlations from PM6-DH2 data for 
HEL data set. 
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Figure 4.5 a) Linear, b) ROC curve and c) rank correlations from OPLSAA data for HEL 
data set. 
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Figure 4.6 a) Linear and b) rank correlations from AMBER94 data for HEL data set. 
ROC curve not shown due to perfect prediction. 
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Table (4.3) reports similar data for the data set consisting of peptides based on MBP. In 
this case, all but two peptides are quite strongly bound to the receptor, and also exhibit 
very low IC50 values. The two exceptions to this are for mutation of Val89 and Phe92, 
which are well-known to be important as “anchor residues”: mutation of these into 
alanine significantly increases IC50 values. All methods considered predict that the F92A 
mutation is particularly weakly bound. The instability of the F92A mutant is most marked 
with the forcefield method: OPLS-AA predicts that this peptide is not bound at all to the 
receptor. In contrast, the semi-empirical methods succeed in predicting the relatively 
weak binding of the V89A mutant, whereas with force field methods this mutant does 
not stand out as being more weakly bound than other peptides. 
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Table 4.3: IC50 values (nM) and interaction energies (kcal/mol) for MBP along with R2, 
rank correlation, and ROC area for each method. 
Peptide  IC50 
MM/ 
GBVI 
RM1-D/ 
COSMO 
PM6-DH2/ 
COSMO 
OPLS-AA/ 
Born 
AMBER94/
Born 
EAPVVHFFKNIVTP 7 -71.09 -20.38 -124.32 -12.86 -14.50 
ENAVVHFFKNIVTP 10 -70.00 -18.01 -125.35 -9.24 -15.18 
ENPAVHFFKNIVTP 10 -68.85 -19.83 -127.46 -10.72 -18.02 
ENPVAHFFKNIVTP 50 -67.19 -15.66 -118.41 -6.64 -14.23 
ENPVVAFFKNIVTP 10 -65.74 -17.54 -124.17 -8.68 -13.08 
ENPVVHAFKNIVTP 10 -67.28 -18.19 -124.50 -6.28 -13.20 
ENPVVHFAKNIVTP 199 -63.90 -13.41 -117.60 +0.05 -5.55 
ENPVVHFFKAIVTP 4 -68.45 -17.22 -113.15 -29.96 -37.80 
ENPVVHFFKNAVTP 4 -70.95 -20.91 -128.37 -14.70 -23.28 
ENPVVHFFKNIATP 4 -69.25 -18.76 -127.31 -9.29 -16.37 
ENPVVHFFKNIVAP 4 -69.35 -21.79 -128.18 -29.98 -34.72 
       
R2  0.57 0.69 0.22 0.46 0.45 
*(IC50-average) rank 
correlation  1.00 0.90 0.60 1.00 0.90 
 
* Rank correlation for the set after taking the average energies for peptides with IC50 = 4 nM 
(underlined) and for peptides with IC50 = 10 nM (bold).   
 
The R2 statistic indicates reasonable correlation between IC50 and RM1-D interaction 
energy, a slightly worse correlation with MM/GBVI data, and poor correlations with 
OPLS-AA, AMBER94 and PM6-DH2 data. Application of the rank correlation statistic is 
not straightforward for this data set, since four peptides have IC50 = 4 nM and a further 
four have IC50 = 10 nM. Therefore, we took the average energies for the peptides with 
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IC50 = 4 nM and the average energies for the peptides with IC50 = 10 nM and used 
these averages on the calculation of the rank correlation of this set. The standard cutoff 
of 1000 nM to distinguish binders from non-binders for ROC analysis is inappropriate in 
this case Figure (4.7) (4.8) (4.9) (4,10) (4.11).  
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Figure 4.7 a) Linear and b) rank correlations from MM/GBVI data for MBP data set. 
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Figure 4.8 a) Linear and b) rank correlations from RM1-D data for MBP data set. 
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Figure 4.9 a) Linear and b) rank correlations from PM6-DH2 data for MBP data set. 
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Figure 4.10 a) Linear and b) rank correlations from OPLSAA data for MBP data set. 
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Figure 4.11 a) Linear and b) rank correlations from AMBER94 data for MBP data set. 
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While the results for HEL and MBP data sets are encouraging, the structural similarities 
and restricted range of IC50 data (particularly for MBP) mean that more stringent tests 
are required before we can reach any conclusions on the suitability of the methods 
examined. For this, we employed Southwood et al’s set of 22 structurally diverse 
peptides bound with IC50 values ranging from below 2 to over 2000 nM [11]. Initially, 
SYFPEITHI and SVMHC prediction servers, along with our own implementation of 
Southwood et al’s algorithm, were used to identify the best alignment for each peptide. 
This alignment was then constructed by manual mutation of PDB structure 1AQD in 
MOE, and energy minimized. The peptide on 1AQD PDB structure contains 14 
residues, with the fourth residue located in pocket 1 of the receptor. So, in order to 
mutate this peptide to Southwood’s peptides, we located the anchor residue in pocket 1 
and then mutated the rest of the original peptide from 1AQD to that employed by 
Southwood et al. By using this technique we included the core residues of the peptides 
(located on pocket 1 to pocket 9 of the receptor, the important binder residues) and 
some more residues of the peptides to our calculations, but we missed few residues 
from each peptide on the set. On table (4.4) and (4.5), we underline the residues 
included in our calculations and identify the residue in pocket 1 in bold red.    
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Table 4.4: IC50 values (nM) and interaction energies (kcal/mol) for Southwood data set along with R2, rank correlation, and ROC area 
for each method. 
Peptide No. 
 
Sequence* IC50 
MM/ 
GBVI  
RM1-D/ 
COSMO 
PM6-DH2/ 
COSMO 
OPLS-AA/ 
Born 
AMBER94/ 
Born 
1188.34 HNWVNHAVPLAMKLI 14 -40.62 -85.53 
-152.33 -143.45 -126.40 
1188.16 KSKYKLATSVLAGLL 3.7 -49.04 -182.02 
-246.12 -138.83 -139.35 
1136.47 THHYFVDLIGGAMLSL 2.2 -57.48 -26.04 
-101.91 -145.89 -143.04 
1188.32 GLAYKFVVPGAATPY 3.1 -42.75 -105.60 
-172.91 -129.11 -120.34 
1136.16 LTSQFFLPALPVFTWL 1.6 -53.28 -71.09 
-143.94 -148.22 -138.43 
27.415 NVKYLVIVFLIFFDL 2011 +17.46 -4.54 
-71.56 -93.76 -95.87 
27.403 LVNLLIFHINGKIIK 78 -13.19 -77.91 
-127.79 -168.31 -128.50 
1136.21 IPQEWKPAITVKVLPA 2.2 -36.32 -130.90 
-209.19 -132.11 -117.41 
1136.28 LAAIIFLFGPPTALRS 0.23 -53.05 -90.94 
-161.75 -140.97 -135.16 
1136.11 VVFPASFFIKLPIILA 0.89 -59.32 -84.21 
-146.19 -155.07 -137.81 
1136.14 FATCFLIPLTSQFFLP 5.3 -24.52 -63.29 
-136.09 -133.68 -131.21 
1188.13 AGLLGNVSTVLLGGV 116 -28.96 -86.62 
-149.38 -115.74 -102.50 
1136.24 NLSNVLATITTGVLDI 182 -25.61 -27.96 
-96.12 -113.74 -96.22 
1136.12 IKLPIILAFATCFLIP 105 40.92 -118.30 
-150.80 -107.73 -98.42 
27.392 SSVFNVVNSSIGLIM 41 -38.79 -51.92 
-123.90 -133.96 -123.70 
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27.417 VKNVIGPFMKAVCVE 56 -53.73 -100.38 
-152.69 -128.45 -126.36 
1136.55 QEIDPLSYNYIPVNSN 65 -11.14 -7.50 
-78.95 -119.45 -102.80 
1136.71 EPQGSTYAASSATSVD 5.1 -58.73 -16.20 
-96.59 -127.66 -113.00 
1136.38 SSIIFGAFPSLHSGCC 70 -8.49 -33.79 
-85.15 -90.11 -85.43 
27.388 MRKLAILSVSSFLFV 50 -13.22 -73.82 
-125.30 -143.71 -128.80 
1136.59.01a RVYQEPQVSPPQRAET 130 +29.36 -28.23 
-86.59 -94.42 -110.26 
1136.46 LWWSTMYLTHHYFVDL 68 -9.91 -106.31 
-190.35 -135.71 -128.45 
        
        
R2   0.54 0.14 0.23 0.36 0.48 
Rank 
correlation 
 
 
0.78 0.29 0.48 0.66 0.74 
ROC area   0.93 0.62 0.75 0.79 0.87 
* The underlined residues are the residues which we included in our calculations and the residues on bold red are the residue which 
located on pocket one of the receptor.    
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Figure 4.12 a) Linear, b) ROC curve and c) rank correlations from MM/GBVI data for 
Southwood data set. 
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Figure 4.13 a) Linear, b) ROC curve and c) rank correlations from RM1-D data for 
Southwood data set. 
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Figure 4.14 a) Linear, b) ROC curve and c) rank correlations from PM6-DH2 data for 
Southwood data set. 
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Figure 4.15 a) Linear, b) ROC curve and c) rank correlations from OPLSAA data for 
Southwood data set. 
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Figure 4.16 a) Linear, b) ROC curve and c) rank correlations from AMBER94 data for 
Southwood data set. 
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These structures were then used to examine the performance of the methods discussed 
above in predicting binding energy for this more challenging set of data (Table 4.3). As 
in other data sets considered above, all methods clearly identify the peptide with the 
highest IC50 value, namely 27.415, as being particularly weakly bound. Indeed, 
MM/GBVI predicts this peptide not to be bound at all to the receptor. Across the entire 
set, statistical measures show promising performance for MM/GBVI and 
AMBER94/Born methods, with rather worse performance for OPLS-AA/Born and PM6-
DH2/COSMO, and poor results from RM1-D/COSMO. The MM/GBVI R2 value of 0.54 is 
more than 99.9% significant, and corresponds to a standard error for estimate of log 
(1/IC50) of 0.64 nM. The rank correlation coefficient of 0.78 indicates that this method 
puts almost 80% of peptides in the correct rank order. For ROC results, we used a 
cutoff of 50 nM to distinguish binders from non-binders, resulting in 11 peptides in each 
category, thereby giving a balanced test of predictions. The area under the ROC curve 
of 0.93 found using MM/GBVI is highly encouraging, indicating that very few false 
positives/negatives result from this approach. In contrast, the value of 0.62 for RM1-D is 
only slightly higher than random Figure (4.12) (4.13) (4.14) (4.15) (4.16). 
 
Because of the encouraging performance of MM/GBVI, we then explored whether this 
method could be used to predict alignment of peptides within the receptor, rather than 
relying on purely sequence-based methods. To do this, numerous potential binding 
poses were generated with SYFPEITHI and SVMHC algorithms, and the one with the 
most negative MM/GBVI interaction energy selected. In 20 of the 22 cases, this agreed 
with the results from sequence-based prediction methods, but for two peptides (nos. 
1136.14 and 1136.16) a lower energy alternative was found from this analysis. For the 
1136.14, MM/GBVI predicts Thr as the anchor residue instead of Leu, and for 1136.16, 
the MM/GBVI predicts Gln as the anchor residue instead of Phe. This is illustrated in 
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Figure (4.17) for 1136.16: as might be expected, sequence-based predictions place Phe 
in the hydrophobic environment of pocket 1. However, this leads to placement of Ala 
into pocket 4, Pro in pocket 6 and Thr in pocket 9, none of which are particularly 
favourable for binding. With Gln as the residue in pocket 1, a hydrogen bond can form 
to the side-chain carbonyl (Figure (4.17), bottom left). In addition, this alignment places 
Leu in pocket 4, Ala in pocket 6 and Val in Pocket 9, all of which contribute to 
favourable binding. Comparison of Tables (4.4) and (4.5) shows that the second 
alignment has almost 10 kcal/mol greater binding energy, despite the apparent anomaly 
of a having relatively polar residue in the hydrophobic pocket 1. 
 
 
 
 
Figure 4.17 3D and 2D ligand interaction views of two possible alignments of peptide 
1136.16 in HLA-DR1. Top: Phe in pocket 1; Bottom: Gln in pocket 1. On the left, the 
MHC receptor is shown as a continuous surface, the residue in pocket 1 as space-filling 
CPK spheres, and the remainder of the peptide as white wireframe. On the right, blue-
shading of the peptide residue indicates exposed atoms. 
P1 
P1 
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Using the new values for these two peptides improves all statistical tests slightly, as 
shown in Table (4.5). MM/GBVI data shows small increases in R2 and rank correlation 
coefficient, with plots corresponding to these data shown in Figure (4.18). The area 
under the ROC curve increases from 0.93 to 0.96, again illustrated in Figure (4.18). The 
statistics from other methods are barely affected by this change. Thus, we conclude that 
MM/GBVI interaction energies are a useful addition to sequence-only methods of 
prediction of peptide-MHC-II binding alignments.  
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Table 4.5: IC50 values (nM) and interaction energies (kcal/mol) for Southwood data set from MM/GBVI alignment along with R2, rank 
correlation, and ROC area for each method.a 
Peptide No. 
  
IC50 
MM/ RM1-D/ OPLS-AA/ AMBER94/ PM6-DH2/ 
Sequence* GBVI COSMO Born Born COSMO 
1188.34 HNWVNHAVPLAMKLI 14 -40.62 -85.53 -143.45 -126.4 -152.33 
1188.16 KSKYKLATSVLAGLL 3.7 -49.04 -182.02 -138.83 -139.35 -246.12 
1136.47 THHYFVDLIGGAMLSL 2.2 -57.48 -26.04 -145.89 -143.04 -101.91 
1188.32 GLAYKFVVPGAATPY 3.1 -42.75 -105.6 -129.11 -120.34 -172.91 
1136.16 LTSQFFLPALPVFTWL 1.6 -62.43 -68.14 -146.77 -131.54 -143.94 
27.415 NVKYLVIVFLIFFDL 2011 17.46 -4.54 -93.76 -95.87 -71.56 
27.403 LVNLLIFHINGKIIK 78 -13.19 -77.91 -168.31 -128.5 -127.79 
1136.21 IPQEWKPAITVKVLPA 2.2 -36.32 -130.9 -132.11 -117.41 -209.19 
1136.28 LAAIIFLFGPPTALRS 0.23 -53.05 -90.94 -140.97 -135.16 -161.75 
1136.11 VVFPASFFIKLPIILA 0.89 -59.32 -84.21 -155.07 -137.81 -146.19 
1136.14 FATCFLIPLTSQFFLP 5.3 -64.73 -66.8 -140.92 -130.17 -136.09 
1188.13 AGLLGNVSTVLLGGV 116 -28.96 -86.62 -115.74 -102.5 -149.38 
1136.24 NLSNVLATITTGVLDI 182 -25.61 -27.96 -113.74 -96.22 -96.12 
1136.12 IKLPIILAFATCFLIP 105 40.92 -118.3 -107.73 -98.42 -150.80 
27.392 SSVFNVVNSSIGLIM 41 -38.79 -51.92 -133.96 -123.7 -123.90 
27.417 VKNVIGPFMKAVCVE 56 -53.73 -100.38 -128.45 -126.36 -152.69 
1136.55 QEIDPLSYNYIPVNSN 65 -11.14 -7.5 -119.45 -102.8 -78.95 
1136.71 EPQGSTYAASSATSVD 5.1 -58.73 -16.2 -127.66 -113 -96.59 
1136.38 SSIIFGAFPSLHSGCC 70 -8.49 -33.79 -90.11 -85.43 -85.15 
27.388 MRKLAILSVSSFLFV 50 -13.22 -73.82 -143.71 -128.8 -125.30 
1136.59.01a 
RVYQEPQVSPPQRAET 
130 29.36 -28.23 -94.42 -110.26 -86.59 
1136.46 
LWWSTMYLTHHYFVDL 
68 -9.91 -106.31 -135.71 -128.45 -190.35 
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R2   0.56 0.14 0.36 0.47 0.23 
Rank  
 0.79 0.29 0.66 0.74 0.48 correlation 
ROC area     0.96 0.62 0.8 0.87 0.75 
 
a
 Alignments that differ from Table 3 shown in bold.  
* The underlined residues are the residues which we included in our calculations and the residues on bold red are the residue which 
located on pocket one of the receptor.  
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Figure 4.18 a) Linear correlation, b) rank correlation and c) ROC curve from MM/GBVI 
data for Southwood data set. 
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Figure 4.19 a) Linear correlation, b) rank correlation and c) ROC curve from RM1-D 
data for Southwood data set. 
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Figure 4.20 a) Linear correlation, b) rank correlation and c) ROC curve from OPLSAA 
data for Southwood data set. 
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Figure 4.21 a) Linear correlation, b) rank correlation and c) ROC curve from AMBER94 
data for Southwood data set. 
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Figure 4.22 a) Linear correlation, b) rank correlation and c) ROC curve from PM6-DH2 
data for Southwood data set. 
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4.5 Conclusion:  
We have tested several methods to calculate the interaction energy for peptide-MHC-II 
complexes for three separate data sets, using IC50 data to evaluate the accuracy of 
each theoretical method. We show that MM/GBVI approach is a promising way to 
calculate the free energy for peptide-receptor complexes, with reliable performance for 
all three data sets as measured by three distinct statistical tests. For two data sets 
where peptides are closely related, HEL and MBP, excellent performance is evident 
from these statistics, with strongly significant correlation between interaction energy and 
log(1/IC50) good or perfect ranking of activity, and no false negatives/positives. 
AMBER94 with a Born model of solvation performs almost as well, while OPLS-AA/Born 
and RM1-D/COSMO give rather worse performance. MM/GBVI also performs well for 
the more diverse set of peptides contained in the Southwood data set despite the lack 
of entropy contributions to these calculations, apparently confirming that such 
contributions are not required for this set in evaluation of relative binding free energies 
even for ligands as flexible as peptides.  
 
We also show that this method can be used to predict the anchor residues that reside in 
receptor binding pockets, and that this approach gives slight improvement in statistics 
over purely sequence-based prediction methods such as SYFPEITHI or SVMHC. The 
accuracy of the MM/GBVI approach may stem from the fact that the dielectric constant 
employed is estimated from the atoms present in the specific complex under study, 
rather than on an idealised value, or from the use of constrained optimisation that allows 
ligand and some receptor flexibility while keeping the overall binding mode fixed. Of 
course, both peptide ligand and protein receptor are flexible objects, such that the single 
snapshots used here can only be approximations of the entire binding event. We 
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explored the use of molecular dynamics to calculate MM-GB/SA averaged over multiple 
snapshots, and reported the results in Chapter 5. For now, we have shown that the 
MM/GBVI approach can deliver reasonable predictions of peptide-MHC binding in a 
matter of a few seconds on a desktop computer. 
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Chapter 5: 
Molecular dynamics simulations:  
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5.1 Introduction: 
 
Proteins are very flexible molecules for which the conformation has an important influence in 
their functions [1]: therefore using a single x-ray structure (rigid structure) to study and 
understand their properties such as binding free energy might not be enough. Molecular 
dynamics simulations are usually useful tools in such cases. Molecular dynamics simulation of 
biological molecules can be defined as “the science of simulating the motions of a system of 
particles applied to biological macromolecules”, and “gives the fluctuations in the relative 
positions of the atoms in a protein or in DNA as a function of time”[2].  The first molecular 
dynamic simulation has been done 35 years ago for bovine pancreatic trypsin inhibitor (BPTI) 
which proved that proteins are not rigid structures [1, 3].  After that, many investigations were 
carried out on protein phenomena such as the effect of the solvent [4].  The contribution of 
theoretical chemistry on biology has been improved after introducing molecular dynamic 
simulation with supercomputers[2]. By increasing the computer power, the number of 
molecular dynamic studies on biological macromolecules increased [1, 5].  
 
AMBER suite of programs was used to investigate the influence of the motion on implicit and 
explicit solvents for the Southwood set. This set, as we mentioned on the previous chapter, 
contains 22 peptides which interact with MHC class II as a receptor [6]. The binding free 
energies were calculated by molecular mechanics- generalized -Born surface area 
(MM/GBSA) method using MM/PB(GB)SA script on AMBER for both implicit and explicit 
solvent simulations.  
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5.1.1 Implicit and explicit solvation models:  
Solvent can have an important influence on the structure and properties of biomolecules, so in 
many cases one must consider the effect of solvent in calculations. There are two main 
methods to predict the solvation effect on biomolecular properties [7-9], namely implicit (or 
continuum) and explicit solvation models. Explicit solvent models include the solvent molecule 
explicitly in the calculation, while the implicit solvent models replace the solvent molecules with 
a dielectric continuum or similar medium [10, 11]. Each method has its advantages and 
disadvantages: while explicit solvent models consider the solvent effect in the highest levels of 
detail, they can be expensive and time consuming. On the other hand, implicit solvation 
models are able to ‘‘pre-average’’ solvent effect and therefore reduce the need for 
computationally expensive sampling, making these model widely used in studying 
biomolecules [12]. 
 
5.2 Methodology:  
 The calculations are divided in to three stages; preparation, simulation and analyzing the 
output files.  
5.2.1 Preparation: 
The first stage is the preparation which was done by using LEaP program which is provided by 
AMBER. This program is designed to read atoms coordination, topology and force field which 
are required to run the simulations. In this study ff99SB force field was used, which is 
recommended by AMBER [13].  xleap which is the graphic version of leap that allows seeing 
two-dimensional structure of the molecule under the study was used. We used the PDB files 
which were created by MOE program for the previous calculations. To load the PDB files, we 
used “loadpdb” command, and “edit” command was used to view the structure. The structure 
was then neutralized using AMBER xleap by adding sodium ions (Na+) at positions of high 
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negative electric potential around our molecule using “addions Na+0” command [14]. For the 
explicit solvent calculations, we used truncated octahedral box of water by using TIP3P model 
[15] with 8 angstroms as buffer dimension. This was done by “solvateoct TIP3PBOX 8.0” 
command. Two types of text files were produced from this stage “prmtop” and “inpcrd” files.  
“Prmtop” file includes the topology and the parameters of force field. Where “inpcrd” is the 
atoms coordinates file.  These two files were used on the next stage of the calculations.  
 
5.2.2 Minimization and molecular dynamic simulation: 
The second stage of this experiment was carried out by sander which is one of the AMBER 
programs. Sander “stands for Simulated Annealing with NMR-Derived Energy Restraints, but 
this module is used for a variety of simulations that have nothing to do with NMR 
refinement”[16]. Table A on the appendix shows the keywords, the descriptions and values 
which have been used in this study. In order to make the calculations faster [5], bond lengths 
to hydrogen may be constrained. To do so, SHAKE method [17], which is suitable for 
macromolecules, [5]  is highly recommended for most MD calculations [16]. This method 
integrates “the Cartesian equations of motion of flexible molecules” depending on atomic 
coordinates only and not on time [5]. SHAKE method  also known as an iterative method, 
“since it treats the constraints in an iterative way”[5].  The length of the time step ∆t in MD 
simulation depends on the highest frequency motions, which is the bond stretching, happening 
in the system under the study [5, 16].   SHAKE  deletes the bond stretching freedom of bonds 
to hydrogen, and as a result, a larger timestep can be used [16]. We used  NTC= 2, NTC 
indicates the SHAKE  option (see appendix table A), 2 for constrain the bonds involving 
hydrogen [16]. Also we used a Langevin dynamics approach to control the temperature. 
Sander stage divides into few steps; minimization, heat, equilibrium, and molecular dynamics 
simulations.  All input files are located on the appendix. 
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5.2.2.1 Molecular dynamics simulation for implicit solvent (1ns and 6ns): 
The minimization step is very important to run stable molecular dynamic simulations. In this 
step, the structure of the complex was minimized (reached the closest minimum) in order to 
remove any stress or overlapping of the atoms on the starting structure. The input file is 
specified as imin = 1 to run the minimization, (maxcyc =1000) is the maximum number of 
cycles of minimization with (ncyc =500) the first 500 being steepest descent, (ntb =0) not 
periodic simulation, (cut=12) we used a cutoff of 12 Å, and (igb=1) is to use generalized Born 
solvation model. See the minimization input file (min.in) on the appendix.  
 
After the minimization, we moved to heating step. In this step imin=0 was used because there 
is no minimization, igb=1 generalized Born solvation model was used, ntx=1 was used to read 
the initial coordinates and velocities from inpcrd file, ig=-1 for random number seed, ntt=3 the 
Langevin thermostat was used, and temp0=300 the temperature which the system was kept at. 
The description of all keywords (table A) and the heat input file are on the appendix.  
 
After this step we run a short molecular dynamic simulation (100ps) to test our complex before 
running long simulation. imin=0 was used because there is no minimization, igb=1 generalized 
Born solvation model was used, ntx=1 was used to read the initial coordinates and velocities 
from inpcrd file, ig=-1 for random number seed, ntt=3 the Langevin thermostat was used, and 
temp0=300 the temperature at which the system was kept.The input file for the short 
simulations (md1.in) and the description of these keywords are on the appendix. In this step 
we did not use the SHAKE method because we just run the calculations for short time. After 
completion of this step, production molecular dynamic simulations for subsequent analysis 
were run for longer time (1ns); the relevant input file (md2.in) is in the appendix. We used 
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shake option (ntc=2, ntf=2) , turned the minimization off, used 12 Å cutoff, used Born implicit 
solvent, wrote the coordinates on  file every 200 steps, and for temperature Langevin 
thermostat was used to keep the temperature at 300 K. The molecular dynamic simulation was 
run for a total of 500000 steps with a 2fs time step.  
 
In order to investigate the stability of the results based on the length of the simulation, some of 
the implicit solvent simulations were run up to 6 ns. Because of the cost for such calculations, 
this was done for just for three peptides (1136.11, 27.415, and 27.417) as an additional five 
molecular dynamic simulations each 1ns, and for longer simulations for two peptides 27.415 
and 27.417. The molecular dynamics simulations were continued, starting from the last 
structure file from the previous simulation.  After finishing all the molecular simulations for this 
step we moved to the analyzing stage.  
 
5.2.2.2 Molecular dynamic for explicit solvent simulation with periodic boundaries (1ns): 
It has been mentioned before that for explicit solvent, a truncated octahedral box of water 
TIP3P model was used. At this stage, the water has not been affected by the solute, which 
may lead to unstable simulation. Therefore it is important to run a minimization before heating 
the system slowly to 300 K, to relax the water box during a molecular dynamic equilibrium 
stage before running the molecular dynamic simulations[14].  
 
This section (explicit solvent) is more complex than the previous section and it takes longer 
time. The explicit solvent minimization step was divided into two steps; first the protein-ligand 
complex was held fixed, and allows just the water molecules and ions to minimize (min1.in), 
and second, the whole system was minimized (min2.in). In order to hold the complex fixed, 
position restraint (ntr=1) was used based on the “GROUP input” which is classified in the 
 132 
minimization input file (min1.in). A force constant of 500 kcal mol-1 angstrom-2 and restrain 
residues 1 through 379 (as an example) are used.  Then the second step (min2.in) started 
using the previous restrt file.  After minimizing the system, the simulation was moved to the 
equilibration stage starting with heating the system from 0K to 300K by using Langevin 
temperature equilibration method (NTT=3) which is performing very well on “maintaining and 
equalizing” the system temperature [14]. A weak restraint was used, as in the first step in the 
minimization, to ensure this heating occurs without any change in the protein-ligand complex. 
The minimization input files (min1.in) and (min2.in) and the heating input file (heat.in) are in the 
appendix. 
 
After the heating step, the simulation was moved to the equilibration step using constant 
pressure in order to relax the water density. After the system reached the 300 K, the restraints 
on our protein-ligand complex were removed and 100ps simulation time starting from (restrt) 
file from the heat step. The equilibration input file (equl.in) is in the appendix. After that, the 
molecular dynamic simulations were run for 1ns time. See the input file (md2.in) in the 
appendix. This step took a long time to complete, as expected. The molecular dynamic 
simulation for 1ns in implicit solvent takes on average 24 hours while in explicit solvent it takes 
on average 72 hours.  So, explicit solvent simulation requires three times more than implicit 
solvent simulation for each 1ns. 
 
5.2.3 Analyzing the results stage:   
At this stage, three methods were used to analyze the results. First, (process_mdout.perl) 
script from AMBER [14] was used to extract the energies, and other properties from the md.out 
files.  This script creates a numbers of files that contain the properties of the complexes such 
as energies and temperatures vs. time. Second, MM/GBSA method was used to calculate the 
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binding free energies of these peptide-MHC complexes. By taking the average of the 
trajectory, many properties such as energies and temperatures of the molecules can be 
obtained. And because of neglecting entropy term, I focused on calculating the binding free 
energy using MM/GBSA method. In order to get the backbone atom root mean square 
deviation (RMSD) vs. Time, the third program (ptraj) was used, which is a trajectory analysis 
program on AMBER.   
For the implicit solvent simulation for 1ns, several statistical tests were used to investigate the 
influence of the molecular dynamic simulations on the binding free energies of the Southwood 
set. The binding free energies were calculated by MM/GBSA method. And also to test the 
ability of this method on the prediction of peptide-MHCII bonding, using published IC50 values 
as a test. Specifically, I employed the standard Pearson R2 value against the negative log of 
IC50 values, Spearman’s rank correlation coefficient [18], and area under relative operating 
characteristic (ROC) curves by using the ROCkit package [19, 20]. In each case, a value of 1.0 
indicates the ideal of perfect prediction. 
5.3 Results and discussions: 
The previous chapter concentrated on studying a single structure of each peptide. In this 
chapter, molecular dynamic simulations were used to investigate the influence of the motion on 
calculate the binding free energy of peptide-MHC complexes. In this chapter, the calculation 
was divided to four sections; MD simulations on implicit solvent for 1ns time, MD simulations 
on implicit solvent for 6ns time, MD simulations on implicit solvent for longer time and MD 
simulations on explicit solvent for 1ns time. 
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5.3.1 Implicit solvent simulations (1ns): 
First calculations were done on an implicit solvent and were running for 1 ns. Figure (5.1) 
shows the plots of total energy, potential energy and temperature as a function of time for 
1136.11 peptide, and figures A and B on the appendix show these plots for two peptides 
(27.415 and 27.417) from Southwood’s set. The other complexes show the same behavior 
(figures not shown). These three peptides were chosen to cover a wide activity range: 27.415 
has IC50=2011 nM, and is considered as inactive; 27.417 has IC50=56 nM and is considered 
active; and 1136 has IC50 = 0.89 nM is considered a very active peptide.  
 
From the plots in Figure (5.1), it is clear that the simulations were running well and no strange 
behavior was accrued during the simulations. The temperature for example remained more or 
less constant during the simulations.  Figure (5.2) shows the plots of the backbone rms 
deviation (RMSD) of these three peptides from initial structures as a function of time. From 
these plots and Table (5.1), we can see that the peptides structures have been changed during 
the simulations but they were close to the initial structures.  After checking that the simulations 
were run well, I calculated the binding free energy of Southwood set peptide-MHC complexes 
using MM/GBSA method provided by AMBER. Table (5.1) shows the free energies of the set 
by MM/GBSA method. 
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Figure 5.1: The plots of a) potential energy (kcal/mole), b) total energy (kcal/mole) and c) 
temperature (K) as a function of time of (1136.11) peptide. 
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Figure 5.2: The plots of backbone RMSD of a) 1136.11, b) 27.415, and c) 27.417 peptides 
from initial structures as a function of time. 
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Table 5.1: MM/GBSA free energies (kcal/mole) and standard deviation values of Southwood 
set of peptide-MHC complexes after molecular dynamic simulations for 1ns.  
 
Peptide No. IC50 MD/MM-GBSA Std. Dev. 
1188.34 14 -129.89 4.95 
1188.16 3.7 -145.50 7.82 
1136.47 2.2 -127.22 5.32 
1188.32 3.1 -122.89 6.86 
1136.16 1.6 -115.68 7.13 
27.415 2011 -88.89 7.40 
27.403 78 -119.26 6.61 
1136.21 2.2 -130.71 7.50 
1136.28 0.23 -121.62 5.36 
1136.11 0.89 -126.28 6.00 
1136.14 5.3 -113.77 5.69 
1188.13 116 -116.23 5.85 
1136.24 182 -112.00 6.01 
1136.12 105 -106.06 5.09 
27.392 41 -120.59 5.49 
27.417 56 -107.25 5.48 
1136.55 65 -121.05 8.45 
1136.71 5.1 -102.48 5.14 
1136.38 70 -87.42 5.12 
27.388 50 -115.92 6.54 
1136.59.01a 130 -107.69 5.76 
1136.46 68 -133.30 6.99 
Rank 
correlation  0.54  
R^2  0.28  
ROC area  0.77  
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Figure 5.3: The Spearman’s rank correlation of the free energy of Southwood set after 
molecular dynamic simulations on an implicit solvent for 1 ns by MM/GBSA method.   
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Figure5.4: The standard Pearson R2 of the free energy of Southwood set after molecular 
dynamic simulations on an implicit solvent for 1 ns by MM/GBSA method.   
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Figure 5.5: The ROC curve of the free energy of Southwood set after molecular dynamic 
simulations on an implicit solvent for 1 ns by MM/GBSA method.   
 
 
From the statistical tests (Table (5.1), Figure (5.3), (5.4) (5.5)), we can see that the results are 
less encouraging than the results from our previous calculations of MM/GBVI for a single x-ray 
structure. The rank correlation coefficient of 0.54 indicates that this method puts  slightly more 
than 50% of peptides in the correct rank order.  For ROC results, I used a cutoff of 50 nM to 
distinguish binders from non-binders was used, resulting in 11 peptides in each category, 
thereby giving a balanced test of predictions. The area under the ROC curve of 0.77 is less 
encouraging, comparing with the results from MM/GBVI method in previous chapter. The 
standard Pearson R2 value of 0.28 indicates that this approach does not reach the accuracy of 
MM/GBVI method for a single x-ray structure by MOE program which gives R2 = 0.56, rank 
correlation coefficient = 0.79 , and area under the ROC curve = 0.96.  
 
5.3.2 Implicit solvent simulations (6ns): 
To investigate the stability of the results based on the length of the simulation, the simulations 
in this section were run up to 6 ns on an implicit solvent. Because of the cost for such 
calculations, we decided to run the simulations just for three peptides (1136.11, 27.415, and 
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27.417). It has been found that running several short molecular dynamic simulations provide 
more sample “conformations in the vicinity of the native structure” [21]. And the results by 
taking the averages over several molecular dynamic trajectories are different  from those 
obtained from individual trajectories [21]. So, for each peptide, we ran an additional five 
molecular dynamic simulations each 1ns. Figure (5.6) shows the plots of total energy, potential 
energy and temperature as a function of time for (27.415) peptide. The other complexes show 
the same behavior; figures not shown. From these plots, it is clear that the simulations were 
running well and no strange behavior was accrued during the simulations. The temperature for 
example remained more or less constant during the simulations.  Figure (5.7) shows a plot of 
backbone RMSD of 27.415 peptide from initial structure as a function of time. The other 
complexes show the same behavior; figures not shown. From Figures (5.6) and (5.7) and 
Table (5.2), we can see that the peptides structures have been changed during the simulations 
but they were close to the initial structures. The most noticeable change happened between 
2.5 to 3ns Figure (5.7). After checking that the simulations were run well, we calculated the 
free energies of the Southwood set peptide-MHC complexes using MM/PBSA method 
provided by AMBER. Table (5.2) shows the free energies of the set by MM/GBSA method. 
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Figure5.6: The plots of a) potential energy (kcal/mole), b) total energy (kcal/mole) and c) 
temperature (K) as a function of time of (27.415) peptide. 
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Figure5.7: The plot of backbone RMSD of 27.415 peptide from initial structures as a function of 
time (6ns).  
 
 
 
Table 5.2: MM/GBSA free energies (kcal/mole) and standard deviation values of 1136.11, 
27.415, and 27.417 peptides after each 1ns simulations and the averages.  
 
Peptide 
No: 1136.11   27.417   27.415   
Time ns MM/GBSA Std. Dev.  MM/GBSA Std. Dev.  MM/GBSA Std. Dev.  
1 -126.28 6.00 -107.25 5.48 -88.89 7.40 
2 -135.90 6.05 -111.96 5.76 -95.23 5.35 
3 -131.17 6.52 -124.15 5.90 -100.24 6.41 
4 -142.37 7.30 -105.83 5.31 -100.79 4.51 
5 -139.66 6.16 -112.74 6.96 -95.27 6.40 
6 -117.45 7.50 -113.05 5.60 -100.25 4.03 
Average -132.14 10.69 -112.50 8.28 -96.78 7.14 
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 Figure 5.8: The MM/GBSA free energies plots and standard deviation for a) 1136.11, b) 27.415 
and c) 27.417 peptides for each 1ns from 1ns to 6ns time.  
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 Figure5.9: Compare the MM/GBSA free energies plots and standard deviation for 1136.11, 
27.415 and 27.417 peptides during 6ns simulations.  
 
 
By comparing the results and the energies, average energies and standard deviation values of 
these three peptides after simulations for 6ns with the results of these peptides after 1ns, it has 
been found that there is no big influence of running the simulation between 1ns and 6ns time 
on the results of MM/GBSA free energies of these peptide-MHC complexes. And by comparing 
the time required for each 1ns with 6X 1ns time (six time longer for 6ns), we found that running 
the simulations for 6ns does not improve the MM/GBSA calculations sufficiently to warrant 
repeating such simulations for the remaining 19 peptides. Therefore, we did not run the 6ns 
simulation for the all peptides on Southwood set.  Also, from Table (5.3) and the Figures above 
(5.8 and 5.9), it is obvious that the non-active peptide (27.415) got lower free energy 
comparing with the two active peptides. And for these three peptides, MM/GBSA method 
successfully predicts the correct rank order of these three peptides based on IC50 values, and 
save this order during the whole simulations of 6ns.  
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5.3.3 Implicit solvent simulations for longer time:  
In order to investigate the effect of longer simulations, longer molecular dynamics were run for 
two peptides 27.415 and 27.417 starting from 6ns .rst files. The results of the binding free 
energy for these peptides were calculated by MM/GBSA are shown on Table (5.3) and Figure 
(5.10). 
 
Table 5.3: MM/GBSA free energies (kcal/mole) and standard deviation values of 27.415 (up to 
10ns) and 27.417 (up to 13ns) after each 1ns simulations.  
 
 27.417  27.415  
Time ns MMPBSA Std. Dev.  MMPBSA Std. Dev.  
1 -107.25 5.48 -88.89 7.40 
2 -111.96 5.76 -95.23 5.35 
3 -124.15 5.90 -100.24 6.41 
4 -105.83 5.31 -100.79 4.51 
5 -112.74 6.96 -95.27 6.40 
6 -113.05 5.60 -100.25 4.03 
7 -116.86 6.35 -89.7 6.09 
8 -118.73 4.53 -80.6 6.69 
9 -112.68 5.82 -95.91 5.37 
10 -97.42 4.99 -87.6 7.62 
11 -111.51 6.95 - - 
12 -112.67 6.99 - - 
13 -109.85 6.59 - - 
 
 
From these results it is very obvious that the peptide-receptor binding is truly affected by these 
molecular dynamics simulations. However, the changes on the binding free energies after 
each 1ns simulations for these two peptides are small especially between the simulations after 
1ns and after 13ns simulation time for 27.417 and 10ns for 27.425. The binding free energy for 
27.417 after 1 ns simulation is (-107.25) and after 13 ns is (-109.85) kcal/mole. Similar 
conclusion for 27.415 after 1 ns simulation time the binding free energy is (-88.89) and after 10 
ns is (-87.6) kcal/mole. By taking the averages of the binding free energies for these peptides 
simulations, it has been found that the average binding energy for 27.417 is (-111.9) and for 
27.415 is (-93.45) kcal/mole. Table (5.3) also shows that MM/GBSA method successfully 
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predicts the correct rank order of these two peptides based on IC50 values, and save this order 
during the whole simulations times.  
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Figure 5.10: The MM/GBSA free energies plots and stander deviation for a) 27.415 peptide 
from 1ns to 10 ns and b) 27.417 peptide from 1ns to 13ns time. 
 
Figure(5.11) shows the receptor binding site including 27.417 peptide after 1ns, 7ns, and 12ns 
times. This figure provides more evidence that the peptide-receptor binding is truly affected by 
these molecular dynamics simulations.  
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Figure 5.11: the 27.417 peptide in the binding site of the receptor (MHC II) after 1ns, 7ns, and 
12ns simulation times. 
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Based on the results and the lack of time, it has been found that longer simulations take a lot 
of time and are not worth the extra resource. Therefore, longer simulations were not preferable 
to be run.  
 
5.3.4 Explicit solvent simulations: 
So far, all these simulations were done on implicit solvent. In our final section of the molecular 
dynamics simulations, we considered the explicit solvent (water) in the calculation. And 
because of the expensive cost of such simulations, three peptides (1136.11, 27.415 and 
27.417) were considered in this section and were running for 1ns time. Figure (5.12) shows the 
plots of total energy, potential energy and temperature as a function of time for (1136.11) 
peptide, and figures C and D on the appendix show these plots for two peptides, (27.415 and 
27.417) from Southwood’s set. From these plots, it is clear that the simulations were running 
well and no strange behavior was accrued during the simulations. The temperature for 
example remained more or less constant during the simulations.  Figure (5.13) shows the plots 
of the backbone RMSD of these three peptides from initial structures as a function of time. 
From these plots and Table (5.4), we can see that the peptides structures have been changed 
during the simulations but they were close to the initial structures.  After checking that the 
simulations were run well, we calculated the free energies of these three peptides using 
MM/GBSA method provided by AMBER. Table (5.4) shows the free energies by MM/GBSA 
method. 
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 Figure5.12: The plots of a) potential energy (kcal/mole), b) total energy (kcal/mole) and c) 
temperature (K) as a function of time of (1136.11) peptide on explicit solvent (water).  
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 Figure5.13: The plots of backbone RMSD of a) 1136.11,b) 27.415, and c) 27.417 peptides 
from initial structures as a function of time on explicit solvent (water).  
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Table 5.4: MM/GBSA free energies (kcal/mole) and standard deviation values of 1136.11, 
27.415, and 27.417 peptides after 1ns simulations on implicit and explicit solvent (water).  
 
 Explicit solvent Implicit solvent 
Peptide No. MM/GBSA Std. Dev.  MM/GBSA Std. Dev.  
1136.11 -122.91 7.39 -126.28 6.00 
27.415 -111.50 3.70 -88.89 7.40 
27.417 -105.38 4.78 -107.25 5.48 
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Figure5.14: The MM/GBSA free energies plots and stander deviation for 1136.11, 27.415 and 
27.417 peptides for 1ns on explicit solvent and implicit solvent.   
 
 
We can see from Table (5.4) and Figure (5.14), that the results for the two active peptides 
(1136.11 and 27.417) are very close. On the other hand, the results for the non-active peptide 
(27.415) are also not that close.  These results are perhaps not too surprising. The interaction 
between the active peptides and the receptor are strong, therefore the influence of the explicit 
solvent is not very noticeable comparing with non-active peptide. This may mean that the 
presence of water molecules between the peptide and the receptor is responsible for the high 
binding energies for 27.415 peptide Figure (5.15). This peptide has a value of 2011 of IC50, 
where the cutoff of the active peptides is IC50=50 (peptide with IC50 equal to 50 and more is 
consider non-active peptide).     
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Figure5.15: a) 3D structure of (27.415) peptide and water molecules on the active site of the 
receptor. b) 3D structure show the hydrogen bonds (red) between the peptide (blue), water 
molecules (yellow) and three residues from the receptor (green).  
 
 
 
 
 
 
b 
a 
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5.4 Conclusion:  
AMBER suite of programs was used to investigate the influence of the motion in implicit and 
explicit solvents for Southwood set. The binding free energies were calculated by Molecular 
Mechanics Generalized -Born Surface Area (MM/GBSA) method. From the statistic methods 
for implicitly solvated simulation for 1ns, it has been found that the results are less encouraging 
than the results of using MM/GBVI on MOE, which show that the MM/GBVI approach can 
deliver reasonable predictions of peptide-MHC binding in a matter of a few seconds on a 
desktop computer. 
 
Moreover, by increasing the simulation time, and using explicit solvent, the results of 
MM/GBSA show slightly improving but no big changes were found. Therefore, by considering 
the cost of these simulations and the results, we found that implicitly solvated simulation for 
1ns is suitable for such investigation.  
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Chapter 6: 
Conclusions: 
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6.1 Conclusions: 
 
On this study several approximate methods have been used to predict the peptide-protein 
interaction energy in vacuum and in solvent, starting from pairwise interaction, though 
whole peptide-protein interaction and ending with the influence of the motion by using 
molecular dynamics simulations.  
 
For the prediction of the pairwise interaction in vacuum, focussing on the interaction of a 
peptide implicated in multiple sclerosis with its biological MHC receptor, it has been found 
that the semi-empirical RM1 approach with additional correction for dispersion effects 
gives the best prediction comparing with ab initio methods. This study also shows that 
increasing the size of model systems used to represent the bound peptide from single 
amino acids to dipeptides and heptapeptides increases predicting interaction energy, as 
does expanding the number of amino acids used to model the receptor.   
 
For the prediction of the peptide-protein binding energy including the effect of the solvent, 
several methods have been tested to calculate the interaction energy for peptide-MHC-II 
complexes for three separate data sets, using IC50 data to evaluate the accuracy of each 
theoretical method. The results show that MM/GBVI approach is a promising way to 
calculate the binding energy for peptide-protein systems, with reliable performance for all 
three data sets as measured by three distinct statistical tests. MM/GBVI can also be used 
to predict the anchor residues that reside in receptor binding pockets, and this approach 
gives slight improvement in statistics over purely sequence-based prediction methods 
such as SYFPEITHI or SVMHC.  
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Of course, both peptide ligand and protein receptor are flexible objects, such that 
exploring the use of molecular dynamics simulation to calculate the peptide-protein 
binding energy averaged over multiple snapshots was required. AMBER suite of 
programs was used to investigate the influence of the motion in implicit and explicit 
solvents for Southwood set. The binding energies were calculated by Molecular 
Mechanics Generalized -Born Surface Area (MM/GBSA) method. From the statistical 
methods, it has been found that the results are less encouraging than the results of single 
x-ray or “docked” structure using MM/GBVI on MOE, which shows that the MM/GBVI 
approach can deliver reasonable predictions of peptide-MHC binding in a matter of a few 
seconds on a desktop computer.  
 
In conclusion, the prediction of binding energy of peptide-protein system which is mainly 
controlled by non-covalent interactions is not an easy task considering many factors such 
as the effect of the solvent, the size of the complex and the running time of the molecular 
dynamics simulations. These factors play important rolls in such calculations. In this work 
we tried to clarify the effects of these factors and compare the performance of several 
approximation methods.  
 
More investigations on this topic are always required: for example, it would be interesting 
to examine in more detail the role of explicit water in peptide-protein binding. We showed 
in Chapter 5 that water molecules can come between peptide and receptor, but did not 
have time to analyse this data in more detail. Analysis of residence times of individual 
water molecules and their effect on binding energy could be a valuable area for new 
study. Another possible area of future work would be in design of non-peptide molecules 
that can bind to MHC-II receptors, as potential leads for new treatments of MS and 
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related auto-immune diseases. The same methods described in this work, especially 
RM1-D, MM/GBVI and MM/GBSA, can be applied to organic and drug-like molecules. If 
combined with more traditional drug discovery methods such as automated docking 
and/or pharmacophore searching, we may be able to suggest new drug leads for further 
testing.  
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Table A: minimizations and molecular dynamic simulations Keywords, descriptions, and values.
keys and descriptions values used 
imin= to run minimization  0= no minimization just MD simulation 
  1= Perform minimization (no molecular dynamics)  
ntx= Option to read the initial coordinates, velocities and box size from the "inpcrd" file 1= X is read formatted with no initial velocity information (default) 
  7= X, V and BOX(1..3) are read formatted 
irest= to restart the run 0= No effect (default) 
  1= restart calculation 
ntpr= every ntpr steps energy and temperature will be printed on mdinfo file 500, 200 
ntwr= every NTWR steps during dynamics, the "restrt" file will be written 5000 
ntwx= every NTWX steps the coordinates will be written to file "mdcrd". 500, 200 
ntf= force evaluation, If SHAKE is used (see NTC), it is not necessary to calculate forces 
for the constrained bonds 2= bond interactions involving H-atoms omitted (use with NTC=2) 
ntc= Flag for SHAKE to perform bond length constraints 2= bonds involving hydrogen are constrained 
ntb= Periodic boundary. 0=no periodicity is applied 
  1= constant volume (default) 
  2= constant pressure 
ntp= Flag for constant pressure dynamics. This option MUST be set to 1 or 2 when  0= Used with NTB not = 2 (default) 
Constant Pressure periodic boundary conditions are used (NTB = 2).  1= md with isotropic position scaling 
igb= Controls the use of the generalized Born model. 1= the pairwise generalized Born model is used 
ntr= Flag for restraining specified atoms in Cartesian space using a harmonic potential 0= No position restraints (default) 
  1= MD with restraint of specified atoms 
maxcyc= Maximum number of cycles of minimization 1000 
ncyc= After NCYC cycles the method of minimization would be switched from steepest 
descent to conjugate gradient method. 500 
nstlim= Number of MD-steps per NRUN to be performed 25000, 50000, 500000 
temp0= Reference temperature at which the system is to be kept, Default 300 300 
tempi= Initial temperature 0, 300. the velocities will be calculated from the forces instead 
ig= The seed for the random number generator -1 
ntt= For temperature regulation, the Langevin thermostat (NTT=3) is used to maintain the 
temperature of the system at 300 K 3 
This method uses Langevin dynamics with a collision frequency given by gamma_ln   
gamma_In 1 
taup= Pressure relaxation time (in ps), when NTP > 0 2 
cut 12= a cut off of 12 angstroms. 
END= END of this section.   
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Figure A: The plots of a) potential energy (kcal/mole),b) total energy (kcal/mole) and c) 
temperature (K) as a function of time of (27.415) peptide. 
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Figure B: The plots of a) potential energy (kacl/mole), b) total energy (kcal/mole) and c) 
temperature (K) as a function of time of (27.417) peptide. 
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Figure C: The plots of a) potential energy (kcal/mole),b) total energy (kcal/mole) and c) 
temperature (K) as a function of time of (27.415) peptide on explicit solvent (water). 
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Figure D: The plots of a) potential energy (kcal/mole), b) total energy (kcal/mole) and c) 
temperature (K) as a function of time of (27.417) peptide on explicit solvent (water).  
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Input files for molecular dynamics simulation in implicit solvent: 
 
The minimization input file (min.in): 
&cntrl 
  imin   = 1, 
  maxcyc = 1000, 
  ncyc   = 500, 
  ntb    = 0, 
  igb    = 1, 
  cut    = 12 
 / 
 
The heating input file (heat.in):  
Heating up from 0 to 300K 
 &cntrl 
  imin=0,irest=0,ntx=1, 
  nstlim=25000,dt=0.002, 
  ntc=2,ntf=2, 
  cut=12.0, ntb=0, 
  ntpr=500, ntwx=500, 
  ntt=3, gamma_ln=2.0, 
  tempi=0.0, temp0=300.0, 
  igb=1, ig=-1 
 / 
 
Short simulations (md1.in): 
&cntrl 
  imin = 0, ntb = 0, 
  igb = 1, ntpr = 100, ntwx = 100, 
  ntt = 3, gamma_ln = 1.0, 
  tempi = 300.0, temp0 = 300.0 
  nstlim = 100000, dt = 0.001, 
  cut = 12.0 
  ig=-1 
 / 
 
Simulation input file (md2.in):  
&cntrl 
  imin = 0, ntb = 0, 
  igb = 1, ntpr = 200, ntwx = 200, 
  ntc = 2, ntf = 2 
  ntt = 3, gamma_ln = 1.0, 
  tempi = 300.0, temp0 = 300.0 
  nstlim = 500000, dt = 0.002, 
  cut = 12.0 
  ig=-1 
 / 
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Input files for molecular dynamic in explicit solvent simulation: 
 
The minimization input file (min1.in): 
&cntrl 
  imin   = 1, 
  maxcyc = 1000, 
  ncyc   = 500, 
  ntb    = 1, 
  ntr    = 1, 
  cut    = 12 
 / 
Hold the protein fixed 
500.0 
RES 1 379 GROUP input 
END 
END 
 
 
Minimization the whole system (min2.in): 
&cntrl 
  imin   = 1, 
  maxcyc = 2500, 
  ncyc   = 1000, 
  ntb    = 1, 
  ntr    = 0, 
  cut    = 12.0 
 / 
 
The heat input file (heat.in): 
&cntrl 
  imin   = 0, 
  irest  = 0, 
  ntx    = 1, 
  ntb    = 1, 
  cut    = 12.0, 
  ntr    = 1, 
  ntc    = 2, 
  ntf    = 2, 
  tempi  = 0.0, 
  temp0  = 300.0, 
  ntt    = 3, 
  gamma_ln = 1.0, 
  nstlim = 10000, dt = 0.002 
  ntpr = 200, ntwx = 200, ntwr = 2000 
 / 
Keep protein fixed with weak restraints 
10.0 
RES 1 379 
END 
END 
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The equilibrium input file (equl.in): 
&cntrl 
  imin = 0, irest = 1, ntx = 7, 
  ntb = 2, pres0 = 1.0, ntp = 1, 
  taup = 2.0, 
  cut = 12, ntr = 0, 
  ntc = 2, ntf = 2, 
  tempi = 300.0, temp0 = 300.0, 
  ntt = 3, gamma_ln = 1.0, 
  nstlim = 50000, dt = 0.002, 
  ntpr = 500, ntwx = 500, ntwr = 5000 
 / 
 
Molecular dynamic simulations (md2.in):  
&cntrl 
  imin = 0, 
  ntb = 1, 
  cut = 8.0, ntr = 0, 
  ntc = 2, ntf = 2, 
  tempi = 300.0, temp0 = 300.0, 
  ntt = 3, gamma_ln = 1.0, 
  nstlim = 500000, dt = 0.002, 
  ntpr = 200, ntwx = 200, ntwr = 2000 
  ig=-1 
 / 
 
 
 
 
